Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in J Nucl Med

Retrieve available abstracts of 471 articles:
HTML format
Text format



Single Articles


    May 2017
  1. XI M, Liao Z, Hofstetter WL, Komaki R, et al
    FDG-PET Response After Induction Chemotherapy Can Predict Who Will Benefit From Subsequent Esophagectomy After Chemoradiotherapy for Esophageal Adenocarcinoma.
    J Nucl Med. 2017 May 18. pii: jnumed.117.192591. doi: 10.2967/jnumed.117.192591.
    PubMed     Text format     Abstract available


  2. LAMMERTSMA AA
    Forward to the Past: the Case for Quantitative PET Imaging.
    J Nucl Med. 2017 May 18. pii: jnumed.116.188029. doi: 10.2967/jnumed.116.188029.
    PubMed     Text format     Abstract available


  3. KENNEDY-DIXON TG, Gossell-Williams M, Cooper M, Trabelsi M, et al
    Evaluation of radiopharmaceutical adverse reaction reports to the British Nuclear Medicine Society for the period 2007 to 2016.
    J Nucl Med. 2017 May 18. pii: jnumed.117.194092. doi: 10.2967/jnumed.117.194092.
    PubMed     Text format     Abstract available


  4. HOPE TA, Aggarwal R, Chee B, Tao D, et al
    Impact of Ga-68 PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2017 May 18. pii: jnumed.117.192476. doi: 10.2967/jnumed.117.192476.
    PubMed     Text format     Abstract available


  5. SCHMUCK S, von Klot CA, Henkenberens C, Sohns JM, et al
    Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer.
    J Nucl Med. 2017 May 18. pii: jnumed.117.193581. doi: 10.2967/jnumed.117.193581.
    PubMed     Text format     Abstract available


  6. FOSS CA, Liu L, Mease RC, Wang H, et al
    Imaging Macrophage Accumulation in a Murine Model of Chronic Pancreatitis with [125I]iodoDPA SPECT-CT.
    J Nucl Med. 2017 May 18. pii: jnumed.117.189571. doi: 10.2967/jnumed.117.189571.
    PubMed     Text format     Abstract available


  7. NEDROW JR, Josefsson A, Park S, Ranka S, et al
    Imaging of programmed death ligand-1 (PD-L1): impact of protein concentration on distribution of anti-PD-L1 SPECT agent in an immunocompetent melanoma murine model.
    J Nucl Med. 2017 May 18. pii: jnumed.117.193268. doi: 10.2967/jnumed.117.193268.
    PubMed     Text format     Abstract available


  8. GOWRISHANKAR G, Hardy J, Wardak M, Namavari M, et al
    Specific Imaging of Bacterial Infection using 6'' -18F-Fluoromaltotriose: A Second Generation PET Tracer Targeting the Maltodextrin Transporter in Bacteria.
    J Nucl Med. 2017 May 10. pii: jnumed.117.191452. doi: 10.2967/jnumed.117.191452.
    PubMed     Text format     Abstract available


  9. FLEDELIUS J, Winther-Larsen A, Khalil AA, Bylov CM, et al
    18F-FDG-PET/CT for very early response evaluation predicts CT response in Erlotinib treated NSCLC patients - A comparison of assessment methods.
    J Nucl Med. 2017 May 10. pii: jnumed.117.193003. doi: 10.2967/jnumed.117.193003.
    PubMed     Text format     Abstract available


  10. STEIGER S, Arvanitakis M, Sick B, Weder W, et al
    Analysis of prognostic values of various PET metrics in preoperative FDG PET for early stage bronchial carcinoma for progression free and overall survival: significantly increased glycolysis is a predictive factor.
    J Nucl Med. 2017 May 10. pii: jnumed.117.189894. doi: 10.2967/jnumed.117.189894.
    PubMed     Text format     Abstract available


  11. VAN DER VOS CS, Arens AI, Hamill J J, Hofmann C, et al
    Metal artifact reduction of CT scans to improve PET/CT.
    J Nucl Med. 2017 May 10. pii: jnumed.117.191171. doi: 10.2967/jnumed.117.191171.
    PubMed     Text format     Abstract available


  12. ALEXANDER PK, Lie Y, Jones G, Sivaratnam C, et al
    Management Impact of Imaging Brain Vesicular Monoamine Transporter type-2 (VMAT2) in Clinically Uncertain Parkinsonian Syndrome (CUPS) with 18F-AV133 and PET.
    J Nucl Med. 2017 May 10. pii: jnumed.116.189019. doi: 10.2967/jnumed.116.189019.
    PubMed     Text format     Abstract available


  13. SIEGEL JA, Sacks B, Pennington CW, Welsh JS, et al
    Dose Optimization to Minimize Radiation Risk for Children Undergoing CT and Nuclear Medicine Imaging is Misguided and Detrimental.
    J Nucl Med. 2017 May 10. pii: jnumed.117.195263. doi: 10.2967/jnumed.117.195263.
    PubMed     Text format     Abstract available


  14. SUBRAMANIAM RM, Jadvar H, Colletti PM, Guimaraes A, et al
    American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Body.
    J Nucl Med. 2017 May 4. pii: jnumed.117.193524. doi: 10.2967/jnumed.117.193524.
    PubMed     Text format     Abstract available


  15. CALAIS J, Czernin J, Eiber M, Fendler WP, et al
    Most intended management changes after 68Ga-DOTATATE PET/CT are implemented.
    J Nucl Med. 2017 May 4. pii: jnumed.117.192450. doi: 10.2967/jnumed.117.192450.
    PubMed     Text format     Abstract available


  16. HOFHEINZ F, Apostolova I, Oehme L, Kotzerke J, et al
    Test-retest variability of lesion SUV and lesion SUR in 18F-FDG PET: an analysis of data from two prospective multicenter trials.
    J Nucl Med. 2017 May 4. pii: jnumed.117.190736. doi: 10.2967/jnumed.117.190736.
    PubMed     Text format     Abstract available


  17. BOOIJ J, Dubroff J, Pryma D, Yu JQ, et al
    Diagnostic performance of the visual reading of 123I-ioflupane SPECT images when assessed with or without quantification in patients with movement disorders or dementia.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189266. doi: 10.2967/jnumed.116.189266.
    PubMed     Text format     Abstract available


  18. KAGNA O, Kurash M, Ghanem-Zouabi N, Keidar Z, et al
    Does antibiotic treatment affect the diagnostic accuracy of FDG PET/CT studies in patients with suspected infectious processes?
    J Nucl Med. 2017 May 4. pii: jnumed.117.192062. doi: 10.2967/jnumed.117.192062.
    PubMed     Text format     Abstract available


  19. KESCH C, Vinsensia M, Radtke JP, Schlemmer HP, et al
    Intra-individual comparison of 18F-PSMA-1007-PET/CT, multi-parametric MRI and radical prostatectomy specimen in patients with primary prostate cancer - a retrospective, proof of concept study.
    J Nucl Med. 2017 May 4. pii: jnumed.116.189233. doi: 10.2967/jnumed.116.189233.
    PubMed     Text format     Abstract available


  20. YANG J, Wiesinger F, Kaushik S, Shanbhag D, et al
    Evaluation of sinus/edge corrected ZTE-based attenuation correction in brain PET/MRI.
    J Nucl Med. 2017 May 4. pii: jnumed.116.188268. doi: 10.2967/jnumed.116.188268.
    PubMed     Text format     Abstract available


    April 2017
  21. WONDERGEM M, van der Zant F, Knol R, Lazarenko S, et al
    18F-DCFPyL PET/CT in the detection of prostate cancer at 60 and 120 minutes ; detection rate, image quality, activity kinetics and biodistribution.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.192658. doi: 10.2967/jnumed.117.192658.
    PubMed     Text format     Abstract available


  22. WONG SQ, Tothill RW, Dawson SJ, Hicks RJ, et al
    Wet or Dry? Are Liquid Biopsy Techniques Competing or Complementary Technologies to PET for Disease Monitoring in Oncology?
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190116. doi: 10.2967/jnumed.117.190116.
    PubMed     Text format    


  23. MORBELLI S, Alama A, Ferrarazzo G, Coco S, et al
    Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an 18F-FDG PET/CT study.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193201. doi: 10.2967/jnumed.117.193201.
    PubMed     Text format     Abstract available


  24. HSU DF, Ilan E, Peterson WT, Uribe J, et al
    Studies of a Next Generation Silicon-Photomultiplier-Based Time-of-Flight PET/CT System.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.189514. doi: 10.2967/jnumed.117.189514.
    PubMed     Text format     Abstract available


  25. AHRENS BJ, Li L, Ciminera AK, Chea J, et al
    Diagnostic PET Imaging of Mammary Microcalcifications using 64Cu-DOTA-alendronate in a Rat Model of Breast Cancer.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190850. doi: 10.2967/jnumed.117.190850.
    PubMed     Text format     Abstract available


  26. ENGBERS EM, Timmer JR, Mouden M, Knollema S, et al
    Prognostic value of myocardial perfusion imaging with CZT SPECT camera in patients suspected for coronary artery disease.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188516. doi: 10.2967/jnumed.116.188516.
    PubMed     Text format     Abstract available


  27. KOGA K, Nagai Y, Hanyu M, Yoshinaga M, et al
    High-contrast PET imaging of vasopressin V1B receptors with a novel radioligand, 11C-TASP699.
    J Nucl Med. 2017 Apr 27. pii: jnumed.116.188698. doi: 10.2967/jnumed.116.188698.
    PubMed     Text format     Abstract available


  28. KASTE SC, Metzger M, Shulkin B
    Reply: Prudence required when using 18F-FDG PET as reference standard for lymphoma detection.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.190652. doi: 10.2967/jnumed.117.190652.
    PubMed     Text format    


  29. KUNZ WG, Jungblut LM, Kazmierczak PM, Vettermann FJ, et al
    Improved Detection of Transosseous Meningiomas Using 68Ga-DOTATATE PET-CT Compared to Contrast-Enhanced MRI.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.191932. doi: 10.2967/jnumed.117.191932.
    PubMed     Text format     Abstract available


  30. DERLIN T, Gueler F, Brasen JH, Schmitz J, et al
    Integrating MRI and chemokine receptor CXCR4-targeted PET for detection of leukocyte infiltration in complicated urinary tract infections after kidney transplantation.
    J Nucl Med. 2017 Apr 27. pii: jnumed.117.193037. doi: 10.2967/jnumed.117.193037.
    PubMed     Text format     Abstract available


  31. YOUNG JD, Abbate V, Imberti C, Meszaros LK, et al
    68Ga-THP-PSMA: a PET imaging agent for prostate cancer offering rapid, room temperature, one-step kit-based radiolabeling.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.191882. doi: 10.2967/jnumed.117.191882.
    PubMed     Text format     Abstract available


  32. FENDLER WP, Calais J, Allen-Auerbach M, Bluemel C, et al
    68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study.
    J Nucl Med. 2017 Apr 13. pii: jnumed.117.190827. doi: 10.2967/jnumed.117.190827.
    PubMed     Text format     Abstract available


  33. O' DOHERTY J, Jauregui-Osoro M, Brothwood T, Szyszko T, et al
    18F-tetrafluoroborate (18F-TFB), a PET probe for imaging sodium-iodide symporter expression: Whole-body biodistribution, safety and radiation dosimetry in thyroid cancer patients.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192252. doi: 10.2967/jnumed.117.192252.
    PubMed     Text format     Abstract available


  34. GERSTNER E
    MRI and PET: noninvasive tools to probe diffuse intrinsic pontine glioma biology.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.192526. doi: 10.2967/jnumed.117.192526.
    PubMed     Text format    


  35. KOSTAKOGLU L
    Reply: Fact sheet about interim and end-of-treatment 18F-FDG PET/CT in lymphoma.
    J Nucl Med. 2017 Apr 6. pii: jnumed.117.190512. doi: 10.2967/jnumed.117.190512.
    PubMed     Text format    


  36. MILLER MP, Kostakoglu L, Pryma D, Yu JQ, et al
    Reader training for the re-staging of biochemically recurrent prostate cancer using fluciclovine (18F) PET/CT.
    J Nucl Med. 2017 Apr 6. pii: jnumed.116.188375. doi: 10.2967/jnumed.116.188375.
    PubMed     Text format     Abstract available


  37. COLLETTI PM
    2016 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2017;58:9N-12N.
    PubMed     Text format    


  38. DONOHOE KJ, Cohen EJ, Giammarile F, Grady E, et al
    Appropriate Use Criteria for Bone Scintigraphy in Prostate and Breast Cancer: Summary and Excerpts.
    J Nucl Med. 2017;58:14N-17N.
    PubMed     Text format    



  39. SNMMI Begins Release of AUC for High-Value Nuclear Medicine Procedures.
    J Nucl Med. 2017;58:13N.
    PubMed     Text format    


  40. ADAMS HJ, Kwee TC
    Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.
    J Nucl Med. 2017;58:684-685.
    PubMed     Text format    


  41. GROHEUX D
    18F-Fluoroestradiol PET to Predict the Response to Neoadjuvant Treatment of Luminal Breast Cancer.
    J Nucl Med. 2017;58:683.
    PubMed     Text format    


    March 2017
  42. ZUKOTYNSKI K, Vajapeyam S, Fahey FH, Kocak M, et al
    Correlation of 18F-FDG PET and MR Apparent Diffusion Coefficient (ADC) Histogram Metrics with Survival in Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.185389. doi: 10.2967/jnumed.116.185389.
    PubMed     Text format     Abstract available


  43. O JH, Jacene HA, Luber B, Wang H, et al
    Quantitation of cancer treatment response by FDG PET/CT: multi-center assessment of measurement variability.
    J Nucl Med. 2017 Mar 30. pii: jnumed.117.189605. doi: 10.2967/jnumed.117.189605.
    PubMed     Text format     Abstract available


  44. CHO SY, Lipson EJ, Im HJ, Rowe SP, et al
    Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early Time-Point FDG-PET/CT Imaging in Patients with Advanced Melanoma.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.188839. doi: 10.2967/jnumed.116.188839.
    PubMed     Text format     Abstract available


  45. WARNDERS FJ, Terwisscha van Scheltinga AG, Knuehl C, van Roy M, et al
    HER3 specific biodistribution and tumor uptake of 89Zr-MSB0010853 visualized by real-time and non-invasive PET imaging.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.181586. doi: 10.2967/jnumed.116.181586.
    PubMed     Text format     Abstract available


  46. SEITH F, Schmidt H, Kunz J, Kuestner T, et al
    Simulation of tracer dose reduction in 18F-FDG-Positron emission tomography / magnetic resonance imaging (PET/MRI): Effects on oncologic reading, image quality and artifacts.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.184440. doi: 10.2967/jnumed.116.184440.
    PubMed     Text format     Abstract available


  47. VERCELLINO L, Ouvrier MJ, Barre E, Cassinat B, et al
    Assessing bone marrow activity in patients with myelofibrosis: results of a pilot study of 18F-FLT PET.
    J Nucl Med. 2017 Mar 30. pii: jnumed.116.188508. doi: 10.2967/jnumed.116.188508.
    PubMed     Text format     Abstract available


  48. BERREVOETS MA, Kouijzer IJ, Aarntzen EH, Janssen MJ, et al
    18F-FDG-PET/CT optimizes treatment in Staphylococcus aureus bacteremia and is associated with reduced mortality.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.191981. doi: 10.2967/jnumed.117.191981.
    PubMed     Text format     Abstract available


  49. SUCKSDORFF M, Rissanen E, Tuisku J, Nuutinen S, et al
    Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.183020. doi: 10.2967/jnumed.116.183020.
    PubMed     Text format     Abstract available


  50. TEUHO J, Saunavaara V, Tolvanen T, Tuokkola T, et al
    Quantitative evaluation of two scatter correction techniques for 18F-FDG brain PET/MR imaging in regard to MR-based attenuation correction.
    J Nucl Med. 2017 Mar 23. pii: jnumed.117.190231. doi: 10.2967/jnumed.117.190231.
    PubMed     Text format     Abstract available


  51. OTTOY J, Verhaeghe J, Niemantsverdriet E, Wyffels L, et al
    Validation of the semi-quantitative static SUVR method for [18F]-AV45 PET by pharmacokinetic modeling with an arterial input function.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.184481. doi: 10.2967/jnumed.116.184481.
    PubMed     Text format     Abstract available


  52. USMANIJ EA, Natroshvili T, Timmer-Bonte JN, Oyen WJ, et al
    The predictive value of early in-treatment FDG-PET/CT response to chemotherapy in combination with bevacizumab in advanced non-squamous non-small cell lung cancer.
    J Nucl Med. 2017 Mar 23. pii: jnumed.116.185314. doi: 10.2967/jnumed.116.185314.
    PubMed     Text format     Abstract available


  53. DE LEON MJ, Li Y, Okamura N, Tsui WH, et al
    CSF clearance in Alzheimer Disease measured with dynamic PET.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.187211. doi: 10.2967/jnumed.116.187211.
    PubMed     Text format     Abstract available


  54. LOHRKE J, Siebeneicher H, Berger M, Reinhardt M, et al
    18F-GP1, a novel fluorine-18 labeled tracer designed for PET imaging of thrombi with high detection sensitivity and low background.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.188896. doi: 10.2967/jnumed.116.188896.
    PubMed     Text format     Abstract available


  55. GOFFIN KE, Joniau S, Tenke P, Slawin K, et al
    Phase 2 study of 99mTc-trofolastat SPECT/CT to identify and localize prostate cancer in intermediate- and high-risk patients undergoing radical prostatectomy and extended pelvic lymph node dissection.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.187807. doi: 10.2967/jnumed.116.187807.
    PubMed     Text format     Abstract available


  56. BLANC-DURAND P, Van Der Gucht A, Aoun Sebaiti M, Abulizi M, et al
    Brain FDG-PET metabolic abnormalities in Macrophagic Myofasciitis: Are They Stable?
    J Nucl Med. 2017 Mar 16. pii: jnumed.117.190876. doi: 10.2967/jnumed.117.190876.
    PubMed     Text format     Abstract available


  57. REYNES-LLOMPART G, Gamez-Cenzano C, Romero-Zayas I, Rodriguez-Bel L, et al
    Performance Characteristics of the Whole-Body Discovery IQ PET/CT System.
    J Nucl Med. 2017 Mar 16. pii: jnumed.116.185561. doi: 10.2967/jnumed.116.185561.
    PubMed     Text format     Abstract available


  58. KIM EE
    Atlas of SPECT/CT.
    J Nucl Med. 2017 Mar 16. pii: jnumed.117.192518. doi: 10.2967/jnumed.117.192518.
    PubMed     Text format    


  59. HOUARD C, Pinaquy JB, Henriques DE Figueiredo B, Mesguich C, et al
    Role of 18F-fluorodeoxyglucose Positron Emission Tomography-Computed Tomography in post-treatment evaluation of anal carcinoma.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.185280. doi: 10.2967/jnumed.116.185280.
    PubMed     Text format     Abstract available


  60. IAGARU AH
    Dual Integrin alphavbeta3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer (68Ga-BBN-RGD).
    J Nucl Med. 2017 Mar 9. pii: jnumed.117.191478. doi: 10.2967/jnumed.117.191478.
    PubMed     Text format    


  61. PAGANI MM, Giuliani A, Oberg J, De Carli F, et al
    Progressive disgregation of brain networking from normal aging to Alzheimer's Disease. Independent Component Analysis on FDG-PET data.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.184309. doi: 10.2967/jnumed.116.184309.
    PubMed     Text format     Abstract available


  62. ADAMS HJ, Kwee TC
    Reply: Interim PET in Hodgkin lymphoma: is it so useless?
    J Nucl Med. 2017 Mar 9. pii: jnumed.117.192294. doi: 10.2967/jnumed.117.192294.
    PubMed     Text format    


  63. DUMAS LS, Briand F, Clerc R, Brousseau E, et al
    Evaluation of anti-atherogenic properties of ezetimibe using 3H-labeled LDL and 99mTc-cAbVCAM1-5 SPECT imaging in ApoE-/- mice fed a paigen diet.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.177279. doi: 10.2967/jnumed.116.177279.
    PubMed     Text format     Abstract available


  64. PRICE EW, Carnazza KE, Carlin SD, Cho A, et al
    89Zr-DFO-AMG102 Immuno-PET to Determine Local HGF Protein Levels in Tumors for Enhanced Patient Selection.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.187310. doi: 10.2967/jnumed.116.187310.
    PubMed     Text format     Abstract available


  65. KANAZAWA M, Ohba H, Nishiyama S, Kakiuchi T, et al
    Effects of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    J Nucl Med. 2017 Mar 9. pii: jnumed.116.189159. doi: 10.2967/jnumed.116.189159.
    PubMed     Text format     Abstract available


  66. SCHEUERMANN JS, Reddin JS, Opanowski A, Kinahan PE, et al
    Qualification of NCI-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.186759. doi: 10.2967/jnumed.116.186759.
    PubMed     Text format     Abstract available


  67. OHIRA H, Mc Ardle B, deKemp RA, Nery PB, et al
    Inter- and Intra- observer agreement of FDG-PET/CT image interpretation in patients referred for assessment of Cardiac Sarcoidosis.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.187203. doi: 10.2967/jnumed.116.187203.
    PubMed     Text format     Abstract available


  68. RAUSCH I, Rischka L, Ladefoged CN, Furtner J, et al
    PET/MRI for oncological brain imaging: A comparison of standard MR-based attenuation corrections with a novel, model-based approach for the Siemens mMR PET/MR system.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.186148. doi: 10.2967/jnumed.116.186148.
    PubMed     Text format     Abstract available


  69. MEIGNAN MA, Cottereau AS, Deau B, Kanoun S, et al
    Interim PET in Hodgkin lymphoma: is it so useless?
    J Nucl Med. 2017 Mar 2. pii: jnumed.117.190462. doi: 10.2967/jnumed.117.190462.
    PubMed     Text format    


  70. VERA P, Thureau S, Chaumet-Riffaud P, Modzelewski R, et al
    Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by F-miso PET/CT in patients with non-small cell lung carcinoma [RTEP5 study].
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.188367. doi: 10.2967/jnumed.116.188367.
    PubMed     Text format     Abstract available


  71. SAVIO A, Funger S, Tahmasian M, Rachakonda S, et al
    Resting state networks as simultaneously measured with fMRI and PET.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.185835. doi: 10.2967/jnumed.116.185835.
    PubMed     Text format     Abstract available


  72. SAUERLAND S
    Randomized trial on PET/CT imaging requires adequate follow-up.
    J Nucl Med. 2017 Mar 2. pii: jnumed.117.191346. doi: 10.2967/jnumed.117.191346.
    PubMed     Text format    


  73. YANG HJ, Dey D, Sykes J, Klein M, et al
    Arterial CO2 as a Potent Coronary Vasodilator: A Preclinical PET/MR Validation Study with Implications for Cardiac Stress Testing.
    J Nucl Med. 2017 Mar 2. pii: jnumed.116.185991. doi: 10.2967/jnumed.116.185991.
    PubMed     Text format     Abstract available


  74. SCHWARZ SW
    SNMMI Leadership Update: Preparing the Next Generation of Nuclear Medicine Professionals.
    J Nucl Med. 2017;58:12N.
    PubMed     Text format    


  75. KRISHNAN S, Otaki Y, Doris M, Slipczuk L, et al
    Molecular Imaging of Vulnerable Coronary Plaque: A Pathophysiologic Perspective.
    J Nucl Med. 2017;58:359-364.
    PubMed     Text format     Abstract available


  76. TERRITO PR, Meyer JA, Peters JS, Riley AA, et al
    Characterization of 11C-GSK1482160 for Targeting the P2X7 Receptor as a Biomarker for Neuroinflammation.
    J Nucl Med. 2017;58:458-465.
    PubMed     Text format     Abstract available


    February 2017
  77. DECLERCQ LD, Rombouts F, Koole M, Fierens K, et al
    Preclinical Evaluation of 18F-JNJ64349311, a Novel PET Tracer for Tau Imaging.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.185199. doi: 10.2967/jnumed.116.185199.
    PubMed     Text format     Abstract available


  78. TAIEB D, Hicks R, Pacak K
    PET imaging for endocrine malignancies: from woe to go.
    J Nucl Med. 2017 Feb 23. pii: jnumed.117.189688. doi: 10.2967/jnumed.117.189688.
    PubMed     Text format    


  79. SCHWARTZ J, Grkovski M, Rimner A, Schoder H, et al
    Pharmacokinetic Analysis of Dynamic 18F-FMISO PET Data in Non-small Cell Lung Cancer.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.180422. doi: 10.2967/jnumed.116.180422.
    PubMed     Text format     Abstract available


  80. BAUM EJ, Cai Z, Bois F, Holden D, et al
    PET Imaging Evaluation of Four Novel Sigma-1 Radiotracers in Nonhuman Primates.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.188052. doi: 10.2967/jnumed.116.188052.
    PubMed     Text format     Abstract available


  81. LI X, Heber D, Cal Gonzales J, Karanikas G, et al
    Association between osteogenesis and inflammation during the progression of calcified plaque as evaluated by combined 18F-NaF and 18F-FDG PET/CT.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.182790. doi: 10.2967/jnumed.116.182790.
    PubMed     Text format     Abstract available


  82. LODGE MA
    Repeatability of Standardized Uptake Value in Oncologic 18F-FDG PET.
    J Nucl Med. 2017 Feb 23. pii: jnumed.116.186353. doi: 10.2967/jnumed.116.186353.
    PubMed     Text format     Abstract available


  83. EINSPIELER I, Rauscher I, Duwel C, Kronke M, et al
    Detection efficacy of hybrid 68Ga-PSMA ligand PET/CT in prostate cancer patients with biochemical recurrence after primary radiation therapy defined by Phoenix criteria.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.184457. doi: 10.2967/jnumed.116.184457.
    PubMed     Text format     Abstract available


  84. ZHANG-YIN J, Dirand AS, Sasanelli M, Correge G, et al
    Equivalent dose rate at 1m of patients with known or suspected neuroendocrine tumor exiting a nuclear medicine department after 68Ga-DOTATOC, 18F-FDOPA or 18F-FDG PET/CT, or 111In-pentetreotide or 123I-mIBG SPECT/CT.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.187138. doi: 10.2967/jnumed.116.187138.
    PubMed     Text format     Abstract available


  85. ANNARITA S, Incerti E, Fallanca F, Bettinardi V, et al
    First evaluation of PET based human biodistribution and dosimetry of 18F-FAZA, a tracer for imaging tumor hypoxia.
    J Nucl Med. 2017 Feb 16. pii: jnumed.113.122671. doi: 10.2967/jnumed.113.122671.
    PubMed     Text format     Abstract available


  86. SOLNES LB, Jones KM, Rowe SP, Pattanayak P, et al
    Diagnostic Value of 18F-FDG PET/CT versus MRI in the Setting of Antibody Specific Autoimmune Encephalitis.
    J Nucl Med. 2017 Feb 16. pii: jnumed.116.184333. doi: 10.2967/jnumed.116.184333.
    PubMed     Text format     Abstract available


  87. BULLICH S, Villemagne VL, Catafau AM, Jovalekic A, et al
    Optimal reference region to measure longitudinal amyloid-beta change with 18F-florbetaben PET.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.187351. doi: 10.2967/jnumed.116.187351.
    PubMed     Text format     Abstract available


  88. GRKOVSKI M, Schoder H, Lee N, Carlin SD, et al
    Multiparametric imaging of tumor hypoxia and perfusion with 18F-FMISO dynamic PET in head and neck cancer.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.188649. doi: 10.2967/jnumed.116.188649.
    PubMed     Text format     Abstract available


  89. KOLBITSCH C, Ahlman MA, Davies-Venn C, Evers R, et al
    Cardiac and respiratory motion correction for simultaneous cardiac PET-MR.
    J Nucl Med. 2017 Feb 9. pii: jnumed.115.171728. doi: 10.2967/jnumed.115.171728.
    PubMed     Text format     Abstract available


  90. FUCHS K, Kuehn A, Mahling M, Guenthoer P, et al
    In vivo hypoxia PET imaging quantifies the severity of arthritic joint inflammation in line with overexpression of HIF and enhanced ROS generation.
    J Nucl Med. 2017 Feb 9. pii: jnumed.116.185934. doi: 10.2967/jnumed.116.185934.
    PubMed     Text format     Abstract available


  91. LE D
    The Mathematics and Biology of the Biodistribution of Radiopharmaceuticals - A Clinical Perspective.
    J Nucl Med. 2017 Feb 9. pii: jnumed.117.191312. doi: 10.2967/jnumed.117.191312.
    PubMed     Text format    


  92. MENDA Y, O'Dorisio TM, Howe J, Schultz MK, et al
    Localization of Unknown Primary Site with 68Ga-DOTATOC PET/CT in Patients with Metastatic Neuroendocrine Tumor.
    J Nucl Med. 2017 Feb 2. pii: jnumed.116.180984. doi: 10.2967/jnumed.116.180984.
    PubMed     Text format     Abstract available


  93. COTTEREAU AS, Hapdey S, Chartier L, Modzelewski R, et al
    Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma.
    J Nucl Med. 2017;58:276-281.
    PubMed     Text format     Abstract available


  94. WANG J, Arulanandam R, Wassenaar R, Falls T, et al
    Enhancing Expression of Functional Human Sodium Iodide Symporter and Somatostatin Receptor in Recombinant Oncolytic Vaccinia Virus for In Vivo Imaging of Tumors.
    J Nucl Med. 2017;58:221-227.
    PubMed     Text format     Abstract available


  95. BAKER SL, Lockhart SN, Price JC, He M, et al
    Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging.
    J Nucl Med. 2017;58:332-338.
    PubMed     Text format     Abstract available


  96. VAN DER MEER LT, Terry SY, van Ingen Schenau DS, Andree KC, et al
    In Vivo Imaging of Antileukemic Drug Asparaginase Reveals a Rapid Macrophage-Mediated Clearance from the Bone Marrow.
    J Nucl Med. 2017;58:214-220.
    PubMed     Text format     Abstract available


    January 2017
  97. RENAUD JM, Moody JB, deKemp RA
    Reply: Variation in maximum count rates during myocardial blood flow quantification using Rubidium-82 PET.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.188086. doi: 10.2967/jnumed.116.188086.
    PubMed     Text format    


  98. WADSWORTH BJ, Pan J, Dude I, Colpo N, et al
    2-18F-Fluoroethanol is a novel positron emission tomography (PET) reporter of solid tumour perfusion.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.183624. doi: 10.2967/jnumed.116.183624.
    PubMed     Text format     Abstract available


  99. HEKMAN MC, Rijpkema M, Bos D, Oosterwijk E, et al
    Detection of micrometastases using SPECT/fluorescence dual-modality imaging in a CEA-expressing tumor model.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.185470. doi: 10.2967/jnumed.116.185470.
    PubMed     Text format     Abstract available


  100. THIE JA
    Need for Glucose Correction for 18F-FDG PET Influenced by Glucose Sensitivities to Types of Tissue and Random Factors.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.188185. doi: 10.2967/jnumed.116.188185.
    PubMed     Text format    


  101. FUIN N DR, Pedemonte S Dr, Catalano OA, Izquierdo-Garcia D, et al
    PET/MR Imaging in the Presence of Metal Implants: Completion of the Attenuation Map from PET Emission Data.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.183343. doi: 10.2967/jnumed.116.183343.
    PubMed     Text format     Abstract available


  102. ZWARTHOED C, El-Galaly TC, Canepari M, Ouvrier MJ, et al
    Prognostic value of bone marrow tracer uptake pattern in baseline PET scan in Hodgkin Lymphoma: results from an International Collaborative Study.
    J Nucl Med. 2017 Jan 26. pii: jnumed.116.184218. doi: 10.2967/jnumed.116.184218.
    PubMed     Text format     Abstract available


  103. LI L, Wu Y, Wang Z, Jia B, et al
    SPECT/CT Imaging of the Novel HER2-targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.183863. doi: 10.2967/jnumed.116.183863.
    PubMed     Text format     Abstract available


  104. GERNGROSS C, Schretter J, Klingenspor M, Schwaiger M, et al
    Active brown fat during 18FDG-PET/CT imaging defines a patient group with characteristic traits and an increased probability of brown fat redetection.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.183988. doi: 10.2967/jnumed.116.183988.
    PubMed     Text format     Abstract available


  105. VAN DIJK JD, Jager PL, van Osch JA, van Dalen JA, et al
    Variation in maximum count rates during myocardial blood flow quantification using Rubidium-82 PET.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.187757. doi: 10.2967/jnumed.116.187757.
    PubMed     Text format    


  106. PLYKU D, Hobbs RF, Huang K, Atkins F, et al
    Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer.
    J Nucl Med. 2017 Jan 19. pii: jnumed.116.179366. doi: 10.2967/jnumed.116.179366.
    PubMed     Text format     Abstract available


  107. BARRIO M, Czernin J, Fanti S, Ambrosini V, et al
    The impact of SSTR-directed PET/CT on the management of patients with neuroendocrine tumor: A systematic review and meta-analysis.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.185587. doi: 10.2967/jnumed.116.185587.
    PubMed     Text format     Abstract available


  108. LEBECH AM, Gaardsting A, Loft A, Graff J, et al
    Whole body 18F-FDG PET/CT is superior to CT as first line diagnostic imaging in patients referred with serious non-specific symptoms or signs of cancer: a randomized prospective study of 200 patients.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.175380. doi: 10.2967/jnumed.116.175380.
    PubMed     Text format     Abstract available


  109. VAN ES SC, Brouwers AH, Mahesh SV, Leliveld-Kors AM, et al
    89Zr-bevacizumab PET: Potential Early Read Out for Efficacy of Everolimus in Metastatic Renal Cell Carcinoma Patients.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.183475. doi: 10.2967/jnumed.116.183475.
    PubMed     Text format     Abstract available


  110. CHEN DL, Cheriyan J, Chilvers E, Choudoury G, et al
    Quantification of Lung PET Images: Challenges and Opportunities.
    J Nucl Med. 2017 Jan 12. pii: jnumed.116.184796. doi: 10.2967/jnumed.116.184796.
    PubMed     Text format     Abstract available


  111. ZHOU X, Boellaard R, Ishiwata K, Sakata M, et al
    In vivo evaluation of [11C]preladenant for PET-imaging of adenosine A2A receptors in the conscious monkey.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.182410. doi: 10.2967/jnumed.116.182410.
    PubMed     Text format     Abstract available


  112. ADAMS HJ, Kwee TC
    Fact sheet about interim and end-of-treatment 18F-FDG PET/CT in lymphoma.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.187815. doi: 10.2967/jnumed.116.187815.
    PubMed     Text format    


  113. SVIRYDENKA H, Delso G, Barbosa FG, Huellner MW, et al
    The effect of susceptibility artifacts related to metal implants on adjacent lesion assessment in simultaneous TOF PET/MR.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.180802. doi: 10.2967/jnumed.116.180802.
    PubMed     Text format     Abstract available


  114. ARAKAWA Y, Nai Y, Shidahara M, Furumoto S, et al
    Prediction of the clinical standardized uptake value ratio in amyloid PET imaging using a biomathematical modeling approach towards the efficient development of a radioligand.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.183566. doi: 10.2967/jnumed.116.183566.
    PubMed     Text format     Abstract available


  115. AFSHAR-OROMIEH A, Sattler LP, Mier W, Hadaschik B, et al
    The clinical impact of additional late PET/CT imaging with 68Ga-PSMA-11 (HBED-CC) in the diagnosis of prostate cancer.
    J Nucl Med. 2017 Jan 6. pii: jnumed.116.183483. doi: 10.2967/jnumed.116.183483.
    PubMed     Text format     Abstract available


  116. CZERNIN J
    Molecular Imaging and Therapy with a Purpose: A Renaissance of Nuclear Medicine.
    J Nucl Med. 2017;58:21A-22A.
    PubMed     Text format    


  117. SCHWARZ SW
    SNMMI Leadership Update: FDA Approval of Imaging Agents: An Exciting Investment in Nuclear Medicine.
    J Nucl Med. 2017;58:20N.
    PubMed     Text format    



  118. SNMMI COR Submits Recommendations, White Paper on Compounded Sterile Radiopharmaceuticals to USP.
    J Nucl Med. 2017;58:16N-17N.
    PubMed     Text format    


  119. MOGHBEL MC, Mittra E, Gallamini A, Niederkohr R, et al
    Response Assessment Criteria and Their Applications in Lymphoma: Part 2.
    J Nucl Med. 2017;58:13-22.
    PubMed     Text format     Abstract available


  120. ORDONEZ AA, Weinstein EA, Bambarger LE, Saini V, et al
    A Systematic Approach for Developing Bacteria-Specific Imaging Tracers.
    J Nucl Med. 2017;58:144-150.
    PubMed     Text format     Abstract available


  121. DETOUR J, Pierre A, Boisson F, Kreutter G, et al
    Effect of Carbidopa on 18F-FDOPA Uptake in Insulinoma: From Cell Culture to Small-Animal PET Imaging.
    J Nucl Med. 2017;58:36-41.
    PubMed     Text format     Abstract available


  122. ENGLAND CG, Ehlerding EB, Hernandez R, Rekoske BT, et al
    Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    J Nucl Med. 2017;58:162-168.
    PubMed     Text format     Abstract available


  123. VAN DER GEEST T, Laverman P, Gerrits D, Walgreen B, et al
    Liposomal Treatment of Experimental Arthritis Can Be Monitored Noninvasively with a Radiolabeled Anti-Fibroblast Activation Protein Antibody.
    J Nucl Med. 2017;58:151-155.
    PubMed     Text format     Abstract available


  124. SIEGEL JA, Pennington CW, Sacks B
    Subjecting Radiologic Imaging to the Linear No-Threshold Hypothesis: A Non Sequitur of Non-Trivial Proportion.
    J Nucl Med. 2017;58:1-6.
    PubMed     Text format     Abstract available


  125. GOLESTANI R, Razavian M, Ye Y, Zhang J, et al
    Matrix Metalloproteinase-Targeted Imaging of Lung Inflammation and Remodeling.
    J Nucl Med. 2017;58:138-143.
    PubMed     Text format     Abstract available


  126. LEURQUIN-STERK G, Celen S, Van Laere K, Koole M, et al
    What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
    J Nucl Med. 2017;58:110-116.
    PubMed     Text format     Abstract available


    December 2016
  127. NOTNI J, Reich D, Maltsev OV, Kapp TG, et al
    In-vivo PET imaging of the "cancer integrin" alphavbeta6 using gallium-68 labelled cyclic RGD nonapeptides.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.182824.
    PubMed     Text format     Abstract available


  128. SHEIKHBAHAEI S, Marcus C, Fragomeni RS, Rowe SP, et al
    Whole Body FDG-PET and FDG-PET/CT in Patients with Suspected Paraneoplastic Syndrome: A Systematic review and Meta-analysis of Diagnostic Accuracy.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.183905.
    PubMed     Text format     Abstract available


  129. GOETZ C, Podein M, Braun F, Weber WA, et al
    Influence of animal heating on PET imaging quantification and kinetics: results on the biodistribution of 18F-tetrafluoroborate and 18F-FDG in mice.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.177949.
    PubMed     Text format     Abstract available


  130. MORIGUCHI S, Kimura Y, Ichise M, Arakawa R, et al
    PET quantification of the norepinephrine transporter in human brain with (S,S)-18F-FMeNER-D2.
    J Nucl Med. 2016 Dec 15. pii: jnumed.116.178913.
    PubMed     Text format     Abstract available


  131. LAFFON E, Marthan R
    Letter: Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures in NSCLC Patients: Dynamic versus Test-Retest Design.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.186676.
    PubMed     Text format    


  132. BHETHANABHOTLA S, Bakhshi S
    Reply: Neither post-treatment PET-CT nor interim PET-CT using Deauville criteria predicts outcome in pediatric Hodgkin lymphoma.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.186114.
    PubMed     Text format    


  133. CHAE SY, Kim SB, Ahn SH, Moon DH, et al
    Reply: 18F-fluoroestradiol positron emission tomography to predict response to neoadjuvant treatment in luminal breast cancer.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.185660.
    PubMed     Text format    


  134. LI X, Rowe SP, Leal JP, Gorin MA, et al
    Quantitative Parameters in PSMA-targeted PET Imaging with 18F-DCFPyL: Variability in Normal Organ Uptake.
    J Nucl Med. 2016 Dec 8. pii: jnumed.116.179739.
    PubMed     Text format     Abstract available


  135. TAMAKI N
    2016 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine.
    J Nucl Med. 2016;57:8N-14N.
    PubMed     Text format    


  136. TREVES ST, Gelfand MJ, Fahey FH, Parisi MT, et al
    2016 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities.
    J Nucl Med. 2016;57:15N-18N.
    PubMed     Text format    


  137. SONG J, Yan R, Wu Z, Li J, et al
    13N-ammonia PET/CT detection of myocardial perfusion abnormalities in Beagle dogs after local heart irradiation.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.179697.
    PubMed     Text format     Abstract available


  138. DIETLEIN F, Kobe C, Neubauer S, Schmidt M, et al
    PSA-stratified performance of 18F- and 68Ga-labeled tracers in PSMA-PET imaging of patients with biochemical recurrence of prostate cancer.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.185538.
    PubMed     Text format     Abstract available


  139. BARRET O, Alagille D, Sanabria S, Comley RA, et al
    Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer's Disease Subjects.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.182881.
    PubMed     Text format     Abstract available


  140. ADAMS HJ, Kwee TC
    Prudence required when using 18F-FDG PET as reference standard for lymphoma detection.
    J Nucl Med. 2016 Dec 1. pii: jnumed.116.187096.
    PubMed     Text format    


    November 2016
  141. HEISS WD, Zaro Weber O
    Validation of MRI Determination on PET Measurements in Ischemic Stroke.
    J Nucl Med. 2016 Nov 22. pii: jnumed.116.185975.
    PubMed     Text format     Abstract available


  142. ELVAS F, Boddaert J, Vangestel C, Pak K, et al
    99mTc-Duramycin SPECT imaging of early tumor response to targeted therapy: a comparison with 18F-FDG PET.
    J Nucl Med. 2016 Nov 22. pii: jnumed.116.182014.
    PubMed     Text format     Abstract available


  143. ULANER GA, Goldman D, Corben A, Lyashchenko S, et al
    A prospective clinical trial of 18F-Fluciclovine PET/CT neoadjuvant therapy response in invasive ductal and invasive lobular breast cancers.
    J Nucl Med. 2016 Nov 17. pii: jnumed.116.183335.
    PubMed     Text format     Abstract available


  144. HATT M, Tixier F, Visvikis D, Cheze Le Rest C, et al
    Radiomics in PET/CT: more than meets the eye?
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.184655.
    PubMed     Text format    


  145. BARRIO M, Spick C, Radu CG, Lassmann M, et al
    Human biodistribution and radiation dosimetry of 18F-CFA, a PET probe targeting the deoxyribonucleoside salvage pathway.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.182394.
    PubMed     Text format     Abstract available


  146. TAGHIPOUR M, Marcus C, Sheikhbahaei S, Mena E, et al
    Clinical Indications & Impact on Management: Fourth and Subsequent Post-therapy Follow-up FDG-PET/CT Scans in Oncology Patients.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.183111.
    PubMed     Text format     Abstract available


  147. AIKAWA T, Naya M, Obara M, Manabe O, et al
    Impaired Myocardial Sympathetic Innervation is Associated with Diastolic Dysfunction in Patients with Heart Failure with Preserved Ejection Fraction: 11C-hydroxyephedrine PET Study.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.178558.
    PubMed     Text format     Abstract available


  148. BETANCUR J, Rubeaux M, Fuchs T, Otaki Y, et al
    Automatic Valve Plane Localization in Myocardial Perfusion SPECT/CT by Machine Learning: Anatomical and Clinical Validation.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.179911.
    PubMed     Text format     Abstract available


  149. KATIYAR P, Divine MR, Kohlhofer U, Quintanilla-Martinez L, et al
    Spectral Clustering predicts tumor tissue heterogeneity using dynamic 18F-FDG PET: a complement to the standard compartmental modeling approach.
    J Nucl Med. 2016 Nov 3. pii: jnumed.116.181370.
    PubMed     Text format     Abstract available


  150. SCHWARZ SW
    SNMMI Leadership Update: Quality Systems Personnel Training Program for Radiopharmaceutical Manufacturing.
    J Nucl Med. 2016;57:22N.
    PubMed     Text format    


    October 2016
  151. KHANAPUR S, Waarde AV, Dierckx RA, Elsinga PH, et al
    Preclinical Evaluation and Quantification of 18F-Fluoroethyl and 18F-Fluoropropyl analogs of SCH442416 as Radioligands for PET Imaging of the Adenosine A2A Receptors in Rat Brain.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.178103.
    PubMed     Text format     Abstract available


  152. HYAFIL F, Pelisek J, Laitinen I, Schottelius M, et al
    Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for positron emission tomography.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.179663.
    PubMed     Text format     Abstract available


  153. HUANG CC, Wu CH, Huang YY, Tzen KY, et al
    Performing Repeated Quantitative Small Animal PET Studies with Arterial Input Functions is Routinely-Feasible in Rats.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.182402.
    PubMed     Text format     Abstract available


  154. NA SJ, Oh JK, Hyun SH, Lee JW, et al
    18F-FDG PET/CT can predict survival of advanced hepatocellular carcinoma patients: A multicenter retrospective cohort study.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.182022.
    PubMed     Text format     Abstract available


  155. CARDINALE J, Schafer M, Benesova M, Bauder-Wust U, et al
    Preclinical Evaluation of [18F]PSMA-1007: A New PSMA-Ligand for Prostate Cancer Imaging.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.181768.
    PubMed     Text format     Abstract available


  156. YANG H, Jenni S, Colovic M, Merkens H, et al
    18F-5-fluoro-aminosuberic acid (FASu) as a potential tracer to gauge oxidative stress in breast cancer models.
    J Nucl Med. 2016 Oct 27. pii: jnumed.116.180661.
    PubMed     Text format     Abstract available


  157. VAN DER GUCHT A, Aoun Sebaiti M, Guedj E, Aouizerate J, et al
    Brain FDG-PET metabolic abnormalities in patients with long-lasting macrophagic myofasciitis.
    J Nucl Med. 2016 Oct 20. pii: jnumed.114.151878.
    PubMed     Text format     Abstract available


  158. VALTORTA S, Moro M, Prisinzano G, Bertolini G, et al
    Metabolic evaluation of non-small cell lung cancer patient-derived xenografts models using [18F]FDG PET: potential tools for early therapy response.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.176404.
    PubMed     Text format     Abstract available


  159. MICHELHAUGH SK, Muzik O, Guastella AR, Klinger NV, et al
    Assessment of tryptophan uptake and kinetics using 1-(2-[18F]fluoroethyl)-L-tryptophan and alpha-[11C]-methyl-L-tryptophan PET imaging in mice implanted with patient-derived brain tumor xenografts.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.179994.
    PubMed     Text format     Abstract available


  160. DESSEROIT MC, Tixier F, Weber WA, Siegel BA, et al
    Reliability of PET/CT shape and heterogeneity features in functional and morphological components of Non-Small Cell Lung Cancer tumors: a repeatability analysis in a prospective multi-center cohort.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180919.
    PubMed     Text format     Abstract available


  161. JANSEN M, Veldhuijzen van Zanten SE, Van Vuurden DG, Huisman M, et al
    Molecular Drug Imaging: 89Zr-bevacizumab PET in Children with Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2016 Oct 20. pii: jnumed.116.180216.
    PubMed     Text format     Abstract available


  162. BEUKINGA J, Hulshoff JB, Dijk LV, Muijs C, et al
    Predicting response to neoadjuvant chemoradiotherapy in esophageal cancer with textural features derived from pre-treatment 18F-FDG PET/CT imaging.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.180299.
    PubMed     Text format     Abstract available


  163. BAUER M, Karch R, Tournier N, Cisternino S, et al
    Assessment of P-glycoprotein Transport Activity at the Human Blood-Retinal Barrier with (R)-11C-verapamil PET.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.182147.
    PubMed     Text format     Abstract available


  164. FAYAD H, Schmidt H, Kuestner T, Visvikis D, et al
    4D MR and attenuation map generation in PET/MR imaging using 4D PET derived deformation matrices: a feasibility study for lung cancer applications.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.178947.
    PubMed     Text format     Abstract available


  165. SPETH SC, Kruitwagen RF, Kleppe M, Pooters IN, et al
    Comparison of intra-operative gamma probe detection with postoperative SPECT/CT of sentinel nodes related to the ovary.
    J Nucl Med. 2016 Oct 13. pii: jnumed.116.183426.
    PubMed     Text format     Abstract available


  166. ORLHAC F, Nioche C, Soussan M, Buvat I, et al
    Understanding changes in tumor textural indices in PET: a comparison between visual assessment and index values in simulated and patient data.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.181859.
    PubMed     Text format     Abstract available


  167. UNTERRAINER M, Galldiks N, Suchorska B, Kowalew LC, et al
    18F-FET PET uptake characteristics in patients with newly diagnosed and untreated brain metastasis.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.180075.
    PubMed     Text format     Abstract available


  168. BAKHSHI S, Bhethanabhotla S, Kumar R, Agarwal K, et al
    Post-treatment PET-CT Rather than Interim PET-CT Using Deauville criteria Predicts Outcome in Pediatric Hodgkin Lymphoma: a Prospective Study Comparing PET-CT versus Conventional Imaging.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.176511.
    PubMed     Text format     Abstract available


  169. GUO T, Brendel M, Grimmer T, Rominger A, et al
    Predicting regional pattern of longitudinal beta-amyloid accumulation by baseline positron emission tomography.
    J Nucl Med. 2016 Oct 6. pii: jnumed.116.176115.
    PubMed     Text format     Abstract available


  170. ROWE SP, Drzezga A, Neumaier B, Dietlein M, et al
    Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  171. MANSI R, Minamimoto R, Macke H, Iagaru AH, et al
    Bombesin-Targeted PET of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  172. BEHESHTI M, Rezaee A, Geinitz H, Loidl W, et al
    Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  173. CECI F, Castellucci P, Mapelli P, Incerti E, et al
    Evaluation of Prostate Cancer with 11C-Choline PET/CT for Treatment Planning, Response Assessment, and Prognosis.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  174. MAPELLI P, Incerti E, Ceci F, Castellucci P, et al
    11C- or 18F-Choline PET/CT for Imaging Evaluation of Biochemical Recurrence of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  175. NITSCH S, Hakenberg OW, Heuschkel M, Drager D, et al
    Evaluation of Prostate Cancer with 11C- and 18F-Choline PET/CT: Diagnosis and Initial Staging.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  176. SPICK C, Herrmann K, Czernin J
    Evaluation of Prostate Cancer with 11C-Acetate PET/CT.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  177. JADVAR H
    PET of Glucose Metabolism and Cellular Proliferation in Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  178. LINDENBERG L, Ahlman M, Turkbey B, Mena E, et al
    Evaluation of Prostate Cancer with PET/MRI.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  179. AFSHAR-OROMIEH A, Babich JW, Kratochwil C, Giesel FL, et al
    The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  180. PANDIT-TASKAR N, Veach DR, Fox JJ, Scher HI, et al
    Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  181. SCHUSTER DM, Nanni C, Fanti S
    Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


  182. IAGARU AH, Mittra E, Colletti PM, Jadvar H, et al
    Bone-Targeted Imaging and Radionuclide Therapy in Prostate Cancer.
    J Nucl Med. 2016;57.
    PubMed     Text format     Abstract available


    September 2016
  183. SCHAEFFERKOETTER JD, Yan J, Soderlund TA, Townsend DW, et al
    Quantitative Accuracy and Lesion Detectability of Low-Dose FDG-PET for Lung Cancer Screening.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.177592.
    PubMed     Text format     Abstract available


  184. WHITWELL J, Graff-Radford J, Singh T, Drubach D, et al
    18F-FDG PET in Posterior Cortical Atrophy and Dementia with Lewy Bodies.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.179903.
    PubMed     Text format     Abstract available


  185. ROWLEY LM N/A, Bradley KM, Boardman P, Hallam A, et al
    Optimization of image reconstruction for yttrium-90 SIRT on a LYSO PET/CT system using a Bayesian penalized likelihood reconstruction algorithm.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.176552.
    PubMed     Text format     Abstract available


  186. CHAE SY, Kim SB, Ahn SH, Kim HO, et al
    A randomized feasibility study of 18F-fluoroestradiol positron emission tomography to predict pathological response to neoadjuvant systemic therapy in estrogen receptor-rich postmenopausal breast cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178368.
    PubMed     Text format     Abstract available


  187. LODGE MA, Holdhoff M, Leal JP, Bag AK, et al
    Repeatability of 18F-FLT PET in a Multi-Center Study of Patients with High Grade Glioma.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.178434.
    PubMed     Text format     Abstract available


  188. AHN SS, Hwang SH, Jung SM, Lee SW, et al
    Evaluation of spleen glucose metabolism in patients with febrile autoimmune diseases using 18F-FDG PET/CT.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.180729.
    PubMed     Text format     Abstract available


  189. ZUKOTYNSKI K, Jadvar H, Hope TA, Subramaniam RM, et al
    SNMMI Comment on the 2016 Society of Surgical Oncology "Choosing Wisely" Recommendation on the Use of PET/CT in Colorectal Cancer.
    J Nucl Med. 2016 Sep 29. pii: jnumed.116.182584.
    PubMed     Text format    


  190. AHMADZADEHFAR H, Azgomi K, Hauser S, Wei X, et al
    68Ga-PSMA-11 PET as a gate-keeper for the treatment of metastatic prostate cancer with radium-223: proof of concept.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178533.
    PubMed     Text format     Abstract available


  191. JOHNBECK CB, Knigge U, Loft A, Berthelsen AK, et al
    Head-to-head comparison of 64Cu-DOTATATE and 68Ga-DOTATOC PET/CT: a prospective study of 59 patients with neuroendocrine tumors.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.180430.
    PubMed     Text format     Abstract available


  192. GARG PK, Lokitz SJ, Nazih R, Garg S, et al
    Biodistribution and Radiation Dosimetry of C-11 Nicotine from Whole Body PET Imaging in Humans.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.180059.
    PubMed     Text format     Abstract available


  193. WOOTEN D, Guehl NJ, Verwer EE, Shoup TM, et al
    Pharmacokinetic evaluation of the tau PET radiotracer [18F]T807 ([18F]AV-1451) in human subjects.
    J Nucl Med. 2016 Sep 22. pii: jnumed.115.170910.
    PubMed     Text format     Abstract available


  194. PALESTRO CJ
    Reply: Opinion on favoring labeled leukocyte imaging over 18F-FDG-PET for diagnosing prosthetic joint infection: Rectifying ongoing misconceptions.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.181669.
    PubMed     Text format    


  195. MANSOR MS, Yaqub M, Boellaard R, Froklage FE, et al
    Parametric methods for dynamic 11C-Phenytoin PET studies.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178707.
    PubMed     Text format     Abstract available


  196. GIESEL F, Schneider F, Kratochwil C, Rath D, et al
    CT radiomic analysis using lymph-node-density profile in correlation to SUV-value for PET/CT based N-Staging.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.179648.
    PubMed     Text format     Abstract available


  197. HOPE TA, Truillet CC, Ehman EC, Afshar-Oromieh A, et al
    Imaging Response to Androgen Receptor Inhibition Using 68Ga-PSMA-11 PET: First Human Experience.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.181800.
    PubMed     Text format     Abstract available


  198. HU Z, Zhao M, Qu Y, Zhang X, et al
    In vivo three-dimensional radiopharmaceutical excited fluorescence tomography.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.180596.
    PubMed     Text format     Abstract available


  199. OKAMOTO S, Thieme A, Allmann J, D'Alessandria C, et al
    Radiation dosimetry for 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: Absorbed dose in normal organs and tumor lesions.
    J Nucl Med. 2016 Sep 22. pii: jnumed.116.178483.
    PubMed     Text format     Abstract available


  200. ROBU S, Schottelius M, Eiber M, Maurer T, et al
    Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer.
    J Nucl Med. 2016 Sep 15. pii: jnumed.116.178939.
    PubMed     Text format     Abstract available


  201. FINDLAY JM, Bradley KM, Wang LM, Franklin JM, et al
    PREDICTING PATHOLOGICAL RESPONSE OF ESOPHAGEAL CANCER TO NEOADJUVANT CHEMOTHERAPY: THE IMPLICATIONS OF METABOLIC NODAL RESPONSE FOR PERSONALISED THERAPY.
    J Nucl Med. 2016 Sep 15. pii: jnumed.116.176313.
    PubMed     Text format     Abstract available


  202. JANI A, Schreibmann E, Rossi PJ, Shelton JW, et al
    Impact of Fluciclovine (18F) Positron Emission Tomography on Target Volume Definition for Post-Prostatectomy Salvage Radiotherapy: Initial Findings from a Randomized Trial.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.176057.
    PubMed     Text format     Abstract available


  203. KASTE SC, Snyder SE, Metzger ML, Sandlund JT, et al
    Comparison of 11C-methionine and 18F-FDG PET-CT for staging and follow-up of pediatric lymphoma.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.178640.
    PubMed     Text format     Abstract available


  204. RASMUSSEN JH, Norgaard M, Hansen AE, Vogelius IR, et al
    Feasibility of Multiparametric Imaging with PET/MR in Head and Neck Squamous Cell Carcinoma.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.180091.
    PubMed     Text format     Abstract available


  205. SKOVGAARD D, Persson M, Brandt-Larsen M, Christensen C, et al
    Safety, dosimetry and tumor detection ability of 68Ga-NOTA-AE105 - a novel radioligand for uPAR PET imaging: first-in-humans study.
    J Nucl Med. 2016 Sep 8. pii: jnumed.116.178970.
    PubMed     Text format     Abstract available


  206. GARRIGUE P, Hache G, Bennis Y, Brige P, et al
    EPO pretreatment of ECFCs enhances functional recovery after transplantation in a rat model of cerebral ischemia through an increase of their homing abilities: a SPECT/CT study.
    J Nucl Med. 2016 Sep 8. pii: jnumed.115.170308.
    PubMed     Text format     Abstract available


  207. JADVAR H
    Pathways to the Future of Nuclear Medicine Task Force: Phase 1 Report.
    J Nucl Med. 2016;57:17N-9N.
    PubMed     Text format    


  208. GORDON L, Lapi SE, Anderson C, Schwarz SW, et al
    Working Together to Advance Women in Nuclear Medicine.
    J Nucl Med. 2016;57:14N.
    PubMed     Text format    


  209. LEBON V, Alberini JL, Pierga JY, Dieras V, et al
    The rate of distant metastases on FDG-PET/CT at initial staging of breast cancer: comparison between women younger and older than 40 years.
    J Nucl Med. 2016 Sep 1. pii: jnumed.116.178749.
    PubMed     Text format     Abstract available


  210. SHRESTHA S, Liow JS, Zoghbi S, Ikawa M, et al
    The 5-HT1A receptor PET radioligand 11C-CUMI-101 has significant binding to alpha1 adrenoceptors in human cerebellum, limiting its use as a reference region.
    J Nucl Med. 2016 Sep 1. pii: jnumed.116.174151.
    PubMed     Text format     Abstract available


  211. PALESTRO CJ
    Radionuclide Imaging of Musculoskeletal Infection: A Review.
    J Nucl Med. 2016;57:1406-12.
    PubMed     Text format     Abstract available


  212. HARMS HJ, Huisman MC, Rijnierse MT, Greuter H, et al
    Noninvasive Quantification of Myocardial 11C-Meta-Hydroxyephedrine Kinetics.
    J Nucl Med. 2016;57:1376-81.
    PubMed     Text format     Abstract available


  213. BAILLIEZ A, Lairez O, Merlin C, Piriou N, et al
    Left Ventricular Function Assessment Using 2 Different Cadmium-Zinc-Telluride Cameras Compared with a gamma-Camera with Cardiofocal Collimators: Dynamic Cardiac Phantom Study and Clinical Validation.
    J Nucl Med. 2016;57:1370-5.
    PubMed     Text format     Abstract available


  214. SINGH P, Gonzalez-Ramos S, Mojena M, Rosales-Mendoza CE, et al
    GM-CSF Enhances Macrophage Glycolytic Activity In Vitro and Improves Detection of Inflammation In Vivo.
    J Nucl Med. 2016;57:1428-35.
    PubMed     Text format     Abstract available


    August 2016
  215. DIMBER R, Guo Q, Bishop C, Adonis A, et al
    Evidence of brain inflammation in patients with Human T Lymphotropic Virus type 1 associated myelopathy (HAM): A pilot multi modal imaging study using [11C] PBR28 PET, MR T1w and DWI.
    J Nucl Med. 2016 Aug 25. pii: jnumed.116.175083.
    PubMed     Text format     Abstract available


  216. BATEMAN T, Dilsizian V, Beanlands R, DePuey EG, et al
    ASNC/SNMMI Position Statement on the Clinical Indications for Myocardial Perfusion PET.
    J Nucl Med. 2016 Aug 25. pii: jnumed.116.180448.
    PubMed     Text format    


  217. D'SOUZA JW, Hensley H, Doss M, Beigarten C, et al
    Cerenkov Luminescence Imaging as a Modality to Evaluate Antibody-based Positron Emission Tomography Radiotracers.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.178780.
    PubMed     Text format     Abstract available


  218. RENAUD JM, Yip K, Guimond J, Trottier M, et al
    Characterization of 3D PET systems for accurate quantification of myocardial blood flow.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.174565.
    PubMed     Text format     Abstract available


  219. KHOSHNEVISAN A, Chuamsaamarkkee K, Boudjemeline M, Jackson A, et al
    18F-Fluorosulfate for PET imaging of the sodium/iodide symporter: synthesis and biological evaluation in vitro and in vivo.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.177519.
    PubMed     Text format     Abstract available


  220. FENDLER WP, Barrio M, Spick C, Allen-Auerbach M, et al
    68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessments: results from a prospective study on 50 patients.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.179192.
    PubMed     Text format     Abstract available


  221. DE BOER P, Piet AH, Oprea-Lager DE, Slotman B, et al
    Letter: PET-guided stereotactic irradiation of prostate cancer lymph node metastases.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.181149.
    PubMed     Text format    


  222. WONG KK, Raffel DM, Bohnen NI, Altinok G, et al
    2-Year Natural Decline of Cardiac Sympathetic Innervation in Idiopathic Parkinson Disease Studied with 11C-Hydroxyephedrine (HED) PET.
    J Nucl Med. 2016 Aug 18. pii: jnumed.116.176891.
    PubMed     Text format     Abstract available


  223. FENDLER WP, Czernin J, Herrmann K, Beyer T, et al
    Variations in PET/MRI operations: Results from an international survey among 39 active sites.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.174169.
    PubMed     Text format     Abstract available


  224. PANAGIOTIDIS E, Alshammari A, Michopoulou S, Skoura E, et al
    Comparison of the impact of 68Ga-DOTATATE and 18F-FDG PET/CT on clinical management in patients with neuroendocrine tumors.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.178095.
    PubMed     Text format     Abstract available


  225. KWEE TC, Basu S, Alavi A
    Letter: Opinion on favoring labeled leukocyte imaging over 18F-FDG-PET for diagnosing prosthetic joint infection: Rectifying ongoing misconceptions.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.181461.
    PubMed     Text format    


  226. ZHANG H, Desai P, Koike Y, Houghton J, et al
    Dual modality imaging of prostate cancer with a fluorescent and radiogallium-labeled GRP receptor antagonist.
    J Nucl Med. 2016 Aug 11. pii: jnumed.116.176099.
    PubMed     Text format     Abstract available


  227. TOURNIER N, Goutal S, Auvity S, Traxl A, et al
    Strategies to inhibit ABCB1- and ABCG2-mediated efflux transport of erlotinib at the blood-brain barrier: a PET study in non-human primates.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.178665.
    PubMed     Text format     Abstract available


  228. ZHANG J, Niu G, Lang L, Li F, et al
    Clinical translation of a dual integrin alphavbeta3 and GRPR targeting PET radiotracer 68Ga-NOTA-BBN-RGD.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.177048.
    PubMed     Text format     Abstract available


  229. TAIEB D, Patronas NJ, Pacak K
    Reply: [68Ga]-DOTATATE PET/CT versus MRI: why the comparison of [68Ga]-DOTATATE PET/CT to an appropriate MRI protocol is essential.
    J Nucl Med. 2016 Aug 4. pii: jnumed.116.180109.
    PubMed     Text format    



  230. Foundation Opens $2-Million Competition for Alpha-Synuclein PET Tracer.
    J Nucl Med. 2016;57:10N.
    PubMed     Text format    


  231. MINOSHIMA S, Drzezga AE, Barthel H, Bohnen N, et al
    SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.
    J Nucl Med. 2016;57:1316-22.
    PubMed     Text format    


  232. DUBASH SR, Keat N, Mapelli P, Twyman F, et al
    Clinical Translation of a Click-Labeled 18F-Octreotate Radioligand for Imaging Neuroendocrine Tumors.
    J Nucl Med. 2016;57:1207-13.
    PubMed     Text format     Abstract available


  233. SANTINI C, Kuil J, Bunschoten A, Pool S, et al
    Evaluation of a Fluorescent and Radiolabeled Hybrid Somatostatin Analog In Vitro and in Mice Bearing H69 Neuroendocrine Xenografts.
    J Nucl Med. 2016;57:1289-95.
    PubMed     Text format     Abstract available


  234. DOUKKY R, Frogge N, Appis A, Hayes K, et al
    Impact of Appropriate Use on the Estimated Radiation Risk to Men and Women Undergoing Radionuclide Myocardial Perfusion Imaging.
    J Nucl Med. 2016;57:1251-7.
    PubMed     Text format     Abstract available


  235. BAUER M, Blaickner M, Philippe C, Wadsak W, et al
    Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in Humans.
    J Nucl Med. 2016;57:1265-8.
    PubMed     Text format     Abstract available


  236. KOBASHI N, Matsumoto H, Zhao S, Meike S, et al
    The Thymidine Phosphorylase Imaging Agent 123I-IIMU Predicts the Efficacy of Capecitabine.
    J Nucl Med. 2016;57:1276-81.
    PubMed     Text format     Abstract available


  237. MEDHORA M, Haworth S, Liu Y, Narayanan J, et al
    Biomarkers for Radiation Pneumonitis Using Noninvasive Molecular Imaging.
    J Nucl Med. 2016;57:1296-301.
    PubMed     Text format     Abstract available


    July 2016
  238. LAMONICA D, Graf DA, Munteanu MC, Czuczman MS, et al
    18F-Fluorodeoxyglucose (FDG) PET for Measurement of Response and Prediction of Outcome to Relapsed/Refractory Mantle Cell Lymphoma (MCL) Therapy with Bendamustine-Rituximab(BR).
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.173542.
    PubMed     Text format     Abstract available


  239. MAZERE J, Lamare F, Fernandez P, Allard M, et al
    123I-iodobenzovesamicol SPECT Imaging of Cholinergic Systems in Dementia with Lewy Bodies.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.176180.
    PubMed     Text format     Abstract available


  240. MELLHAMMAR EM, Dahlbom M, Axelsson J, Strand SE, et al
    Count rate characteristics and image distortion in preclinical PET systems during intratherapeutic radiopharmaceutical therapy imaging.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.175539.
    PubMed     Text format     Abstract available


  241. HUTTERER M, Ebner Y, Riemenschneider MJ, Willuweit A, et al
    Epileptic activity increases cerebral amino acid transport assessed by [18F]-fluoroethyl-L-tyrosine amino acid PET - a potential brain tumor mimic.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.176610.
    PubMed     Text format     Abstract available


  242. JOHNBECK CB, Knigge UP, Langer S, Jakobsen AL, et al
    Prognostic value of 18F-FLT PET in patients with neuroendocrine neoplasms: a prospective head-to-head comparison with 18F-FDG PET and Ki67 in 100 patients.
    J Nucl Med. 2016 Jul 28. pii: jnumed.116.174714.
    PubMed     Text format     Abstract available


  243. GRAVEL G, Gimenez-Roqueplo AP, Halimi P
    Letter: [68Ga]-DOTATATE PET/CT versus MRI: why the comparison of [68Ga]-DOTATATE PET/CT to an appropriate MRI protocol is essential.
    J Nucl Med. 2016 Jul 21. pii: jnumed.116.179960.
    PubMed     Text format    


  244. LIN C, Bradshaw TJ, Perk TG, Harmon S, et al
    Repeatability of Quantitative 18F-NaF PET: A Multicenter Study.
    J Nucl Med. 2016 Jul 21. pii: jnumed.116.177295.
    PubMed     Text format     Abstract available


  245. TAIEB D, Hicks RJ, Pacak K
    Nuclear medicine in cancer theranostics: beyond the target.
    J Nucl Med. 2016 Jul 21. pii: jnumed.116.178343.
    PubMed     Text format    


  246. HORTI AG, Wang Y, Minn IL, Lan X, et al
    18F-FNDP for PET Imaging of Soluble Epoxide Hydrolase (sEH).
    J Nucl Med. 2016 Jul 14. pii: jnumed.116.173245.
    PubMed     Text format     Abstract available


  247. WONG KH, Panek R, Welsh LC, Mcquaid D, et al
    The predictive value of early assessment after one cycle of induction chemotherapy with 18F-FDG-PET/CT and DW-MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma.
    J Nucl Med. 2016 Jul 14. pii: jnumed.116.174433.
    PubMed     Text format     Abstract available


  248. HARADA N, Kimura H, Onoe S, Watanabe H, et al
    Synthesis and Biological Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for Positron Emission Tomography of Prostate Cancer.
    J Nucl Med. 2016 Jul 14. pii: jnumed.116.175810.
    PubMed     Text format     Abstract available


  249. MAYA Y, Werner RA, Schutz C, Wakabayashi H, et al
    11C-methionine PET of myocardial inflammation in a rat model of experimental autoimmune myocarditis.
    J Nucl Med. 2016 Jul 7. pii: jnumed.116.174045.
    PubMed     Text format     Abstract available


  250. NIE X, Laforest R, Elvington A, Randolph GJ, et al
    PET/MR imaging of hypoxic atherosclerosis using 64Cu-ATSM in a rabbit model.
    J Nucl Med. 2016 Jul 7. pii: jnumed.116.172544.
    PubMed     Text format     Abstract available


  251. SCHWARZ SW
    SNMMI Leadership Update: Working Together to Advance Nuclear Medicine and Molecular Imaging.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


  252. SENGUPTA D, Pratx G
    Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy.
    J Nucl Med. 2016;57:1136-40.
    PubMed     Text format     Abstract available


    June 2016
  253. NKOULOU R MD, Fuchs TA Md, Pazhenkottil AP Md, Kuest SM Md, et al
    Absolute Myocardial Blood Flow and Flow Reserve Assessed by Gated SPECT with Cadmium-Zinc-Telluride Detectors Using 99mTc-Tetrofosmin: Head to Head Comparison with 13N-Ammonia PET.
    J Nucl Med. 2016 Jun 30. pii: jnumed.115.165498.
    PubMed     Text format     Abstract available


  254. SEKINE T, Ter Voert EE, Warnock G, Buck A, et al
    Clinical evaluation of ZTE attenuation correction for brain FDG-PET/MR imaging-comparison with atlas attenuation correction.
    J Nucl Med. 2016 Jun 23. pii: jnumed.116.175398.
    PubMed     Text format     Abstract available


  255. KIM EJ, Kim S, Seo HS, Lee YJ, et al
    Novel PET imaging of atherosclerosis with 68Ga-labeled NOTA-Neomannosylated Human Serum Albumin.
    J Nucl Med. 2016 Jun 23. pii: jnumed.116.172650.
    PubMed     Text format     Abstract available


  256. GNESIN S, Canetti L, Adib S, Cherbuin N, et al
    Partition model based 99mTc-MAA SPECT/CT predictive dosimetry compared to 90Y TOF PET/CT post-treatment dosimetry in radioembolisation of hepatocellular carcinoma: A quantitative agreement comparison.
    J Nucl Med. 2016 Jun 15. pii: jnumed.116.173104.
    PubMed     Text format     Abstract available


  257. LIAO GJ, Clark AS, Schubert EK, Mankoff DA, et al
    18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications.
    J Nucl Med. 2016 Jun 15. pii: jnumed.116.175596.
    PubMed     Text format     Abstract available


  258. LAW WP, Wang WY, Moore PT, Mollee PN, et al
    Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study.
    J Nucl Med. 2016 Jun 15. pii: jnumed.115.169870.
    PubMed     Text format     Abstract available


  259. LEURQUIN-STERK G, Van den Stock J, Crunelle CL, de Laat B, et al
    Positive Association Between Limbic Metabotropic Glutamate Receptor 5 Availability and Novelty-Seeking Temperament in Humans: a 18F-FPEB PET study.
    J Nucl Med. 2016 Jun 9. pii: jnumed.116.176032.
    PubMed     Text format     Abstract available


  260. ZHOU M, Melancon M, Stafford RJ, Li J, et al
    Precision Nanomedicine Using Dual Positron Emission Tomography and Magnetic Resonance Temperature Imaging-Guided Photothermal Therapy.
    J Nucl Med. 2016 Jun 9. pii: jnumed.116.172775.
    PubMed     Text format     Abstract available


  261. GROOTJANS W, Tixier F, van der Vos CS, Vriens D, et al
    The impact of optimal respiratory gating and image noise on evaluation of intra-tumor heterogeneity in 18F-FDG positron emission tomography imaging of lung cancer.
    J Nucl Med. 2016 Jun 9. pii: jnumed.116.173112.
    PubMed     Text format     Abstract available


  262. QUAK E, Le Roux PY, Lasnon C, Robin P, et al
    Does PET SUV harmonization impact PERCIST response classification?
    J Nucl Med. 2016 Jun 9. pii: jnumed.115.171983.
    PubMed     Text format     Abstract available


  263. RAUSCHER I, Maurer T, Beer AJ, Graner FP, et al
    Value of 68Ga-PSMA HBED-CC PET for the assessment of lymph node metastases in prostate cancer patients with biochemical recurrence: comparison with histopathology after salvage lymphadenectomy.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173492.
    PubMed     Text format     Abstract available


  264. FAN Z, Calsolaro V, Atkinson RA, Femminella GD, et al
    Flutriciclamide (18F-GE180) PET: first in human PET study of novel 3rd generation in vivo marker of human translator protein.
    J Nucl Med. 2016 Jun 3. pii: jnumed.115.169078.
    PubMed     Text format     Abstract available


  265. FENDLER WP, Schmidt DF, Wenter V, Thierfelder KM, et al
    68Ga-PSMA-HBED-CC PET/CT detects location and extent of primary prostate cancer.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.172627.
    PubMed     Text format     Abstract available


  266. GOMES A, Slart RH, Sinha B, Glaudemans AW, et al
    18F-FDG-PET/CT in the diagnostic workup of infective endocarditis and related intracardiac prosthetic material: a clear message.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.176826.
    PubMed     Text format    


  267. DOOT RK
    Invited Perspective for: 18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.175687.
    PubMed     Text format    


  268. ORLHAC F, Theze B, Soussan M, Boisgard R, et al
    Multi-scale texture analysis: from 18F-FDG PET images to pathological slides.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173708.
    PubMed     Text format     Abstract available


  269. GRANADOS U, Fuster D, Pericas JM, Llopis J, et al
    DIAGNOSTIC ACCURACY OF 18F-FDG PET/CT IN INFECTIVE ENDOCARDITIS AND IMPLANTABLE CARDIAC ELECTRONIC DEVICE INFECTION: A CROSS-SECTIONAL STUDY.
    J Nucl Med. 2016 Jun 3. pii: jnumed.116.173690.
    PubMed     Text format     Abstract available


    May 2016
  270. CYSOUW MC, Kramer GM, Hoekstra OS, Frings V, et al
    Accuracy and precision of partial volume correction in oncological PET/CT studies.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173831.
    PubMed     Text format     Abstract available


  271. WU Y, Yang W, Lu L, Lu Z, et al
    Prediction of CT Substitutes from MR Images Based on Local Diffeomorphic Mapping for Brain PET Attenuation Correction.
    J Nucl Med. 2016 May 26. pii: jnumed.115.163121.
    PubMed     Text format     Abstract available


  272. DERLIN T, Alchalby H, Bannas P, Laqmani A, et al
    Serial 18F-fluorodeoxyglucose positron emission tomography for monitoring treatment response after allogeneic stem cell transplantation for myelofibrosis.
    J Nucl Med. 2016 May 26. pii: jnumed.115.166348.
    PubMed     Text format     Abstract available


  273. KIESS A, Minn IL, Vaidyanathan G, Hobbs RF, et al
    (2S)-2-(3-(1-Carboxy-5-(4-[211At]astatobenzamido)pentyl)ureido)-pentanedioic acid for PSMA-Targeted alpha-Particle Radiopharmaceutical Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.174300.
    PubMed     Text format     Abstract available


  274. LARIMER BM, Wehrenberg-Klee E, Caraballo A, Mahmood U, et al
    Quantitative CD3 PET Imaging Predicts Tumor Growth Response to Anti-CTLA-4 Therapy.
    J Nucl Med. 2016 May 26. pii: jnumed.116.173930.
    PubMed     Text format     Abstract available


  275. BODET-MILIN C, Faivre-Chauvet A, Carlier T, Rauscher A, et al
    Immuno-PET using anti-CEA bispecific antibody and 68Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial.
    J Nucl Med. 2016 May 26. pii: jnumed.116.172221.
    PubMed     Text format     Abstract available


  276. HOSTETLER ED, Walji AM, Zeng Z, Miller P, et al
    Preclinical characterization of 18F-MK-6240, a promising positron emission tomography (PET) tracer for in vivo quantification of human neurofibrillary tangles (NFTs).
    J Nucl Med. 2016 May 26. pii: jnumed.115.171678.
    PubMed     Text format     Abstract available


  277. LEITHNER D, Baltzer P, Magometschnigg H, Wengert G, et al
    Quantitative Assessment of Breast Parenchymal Uptake in 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
    J Nucl Med. 2016 May 26. pii: jnumed.116.174904.
    PubMed     Text format     Abstract available


  278. ORY D, Celen S, Gijsbers R, Van Den Haute C, et al
    Preclinical evaluation of a P2X7 receptor selective radiotracer: PET studies in a rat model with local overexpression of the human P2X7 receptor and in non-human primates.
    J Nucl Med. 2016 May 19. pii: jnumed.115.169995.
    PubMed     Text format     Abstract available


  279. JENTZEN W, Verschure F, van Zon A, van de Kolk R, et al
    Response Assessment of Bone Metastases from Differentiated Thyroid Cancer Patients in the Initial Radioiodine Treatment Using Iodine-124 PET Imaging.
    J Nucl Med. 2016 May 19. pii: jnumed.115.170571.
    PubMed     Text format     Abstract available


  280. DILSIZIAN V
    Highlights from the Updated Joint ASNC/SNMMI PET Myocardial Perfusion and Metabolism Clinical Imaging Guidelines.
    J Nucl Med. 2016 May 19. pii: jnumed.116.176214.
    PubMed     Text format    


  281. CHEN L, Nabulsi N, Naganawa M, Zasadny K, et al
    Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    J Nucl Med. 2016 May 19. pii: jnumed.115.171454.
    PubMed     Text format     Abstract available


  282. HARALAMPIEVA D, Betzel T, Dinulovic I, Salemi S, et al
    Non-invasive Imaging and Tracking of Engineered Human Muscle Precursor Cells for Skeletal Muscle Tissue Engineering Using Positron Emission Tomography.
    J Nucl Med. 2016 May 19. pii: jnumed.115.170548.
    PubMed     Text format     Abstract available


  283. ENGLAND CG, Ehlerding EB, Cai W
    Imaging the biodistribution and performance of transplanted stem cells with PET.
    J Nucl Med. 2016 May 19. pii: jnumed.116.173963.
    PubMed     Text format    


  284. FAHNERT J, Purz S, Javers JS, Heyde CE, et al
    The use of simultaneous 18F-FDG-PET/MRI for the detection of spondylodiscitis.
    J Nucl Med. 2016 May 19. pii: jnumed.115.171561.
    PubMed     Text format     Abstract available


  285. OOSTING SF, van Asselt SJ, Brouwers AH, Bongaerts AH, et al
    89Zr-bevacizumab PET visualizes disease manifestations in patients with von Hippel-Lindau disease.
    J Nucl Med. 2016 May 12. pii: jnumed.115.167643.
    PubMed     Text format     Abstract available


  286. ULANER GA, Hyman D, Ross D, Corben A, et al
    Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using the 89Zr-DFO-trastuzumab PET/CT.
    J Nucl Med. 2016 May 5. pii: jnumed.115.172031.
    PubMed     Text format     Abstract available


  287. SHCHERBININ S, Schwarz AJ, Joshi AD, Navitsky M, et al
    Kinetics of the tau PET tracer 18F-AV-1451 (T807) in subjects with normal cognitive function, mild cognitive impairment and Alzheimer's disease.
    J Nucl Med. 2016 May 5. pii: jnumed.115.170027.
    PubMed     Text format     Abstract available


  288. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Variation of Specific Activities of Ga-68-Aquibeprin and Ga-68-Avebetrin Enables Selective PET-Imaging of Different Expression Levels of Integrins alpha5beta1 and alphavbeta3.
    J Nucl Med. 2016 May 5. pii: jnumed.116.173948.
    PubMed     Text format     Abstract available


  289. CONVERT L, Lebel R, Gascon S, Fontaine R, et al
    Real Time Microfluidic Blood Counting System for PET and SPECT Preclinical Pharmacokinetic Studies.
    J Nucl Med. 2016 May 5. pii: jnumed.115.162768.
    PubMed     Text format     Abstract available


  290. RUHLMANN M, Jentzen W, Ruhlmann V, Pettinato C, et al
    High Level of Agreement between Pretherapeutic 124I PET and Intratherapeutic 131I Images in Detecting Iodine-positive Thyroid Cancer Metastases.
    J Nucl Med. 2016 May 5. pii: jnumed.115.169649.
    PubMed     Text format     Abstract available


    April 2016
  291. HARMS HJ, Hansson NH, Tolbod LP, Kim WY, et al
    Automatic extraction of myocardial mass and volumes using parametric images from dynamic non-gated PET.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.170613.
    PubMed     Text format     Abstract available


  292. PARK GM, Kim YH, Yun SC, Ahn JM, et al
    Anatomical or Functional Evaluation as an Initial Test for Stable Coronary Artery Disease: A Propensity Score Analysis.
    J Nucl Med. 2016 Apr 28. pii: jnumed.115.169318.
    PubMed     Text format     Abstract available


  293. BLAUFOX MD
    PET Measurement of Renal GFR: Is there a role in Nuclear Medicine.
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.174607.
    PubMed     Text format    


  294. HUMBERT O, Riedinger JM, Vrigneaud JM, Kanoun S, et al
    18F-FDG PET derived tumor blood flow changes after one cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer.
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.172759.
    PubMed     Text format     Abstract available


  295. JIANG S, Pogue B
    Invited Perspective for: "Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using FDG-PET/CT".
    J Nucl Med. 2016 Apr 21. pii: jnumed.116.174367.
    PubMed     Text format    


  296. NAGANAWA M, Waterhouse RN, Nabulsi NB, Lin SF, et al
    First in human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.166850.
    PubMed     Text format     Abstract available


  297. KRAMER GM, Frings V, Hoetjes N, Hoekstra OS, et al
    Repeatability of Quantitative Whole Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170225.
    PubMed     Text format     Abstract available


  298. HUAILEI J, Bansal A, Pandey M, Peng KW, et al
    Synthesis of 18F-Tetrafluoroborate (18F-TFB) via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
    J Nucl Med. 2016 Apr 21. pii: jnumed.115.170894.
    PubMed     Text format     Abstract available


  299. KO GB, Yoon HS, Kim KY, Lee MS, et al
    Simultaneous multi-parametric PET/MRI with silicon photomultiplier PET and ultra-high field MRI for small animal imaging.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.170019.
    PubMed     Text format     Abstract available


  300. FREY KA, Koeppe R
    Invited Perspective for Standardized Expression of 18F-NAV4694 and 11C-PiB beta-Amyloid PET Results with the Centiloid Scale.
    J Nucl Med. 2016 Apr 14. pii: jnumed.116.173989.
    PubMed     Text format    


  301. WU J, Lin SF, Gallezot JD, Chan C, et al
    Quantitative analysis of dynamic 123I-mIBG SPECT imaging data in healthy humans with a population-based metabolite correction method.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.171710.
    PubMed     Text format     Abstract available


  302. WEHRENBERG-KLEE E, Turker NS, Heidari P, Larimer BM, et al
    Differential Receptor Tyrosine Kinase PET Imaging for Therapeutic Guidance.
    J Nucl Med. 2016 Apr 14. pii: jnumed.115.169417.
    PubMed     Text format     Abstract available


  303. TADE FI, Cohen MA, Styblo TM, Odewole OA, et al
    Anti-3-[18F] FACBC (Fluciclovine) PET-CT of Breast Cancer An Exploratory Study.
    J Nucl Med. 2016 Apr 7. pii: jnumed.115.171389.
    PubMed     Text format     Abstract available


  304. FAHEY FH, Ziniel SI, Manion D, Baker A, et al
    Administered Activities for Pediatric Nuclear Medicine Procedures and the Impact of the 2010 North American Guidelines on General Hospitals in the United States.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.172148.
    PubMed     Text format     Abstract available


  305. BRACKHAN M, Bascunana P, Postema JM, Ross TL, et al
    Serial quantitative TSPO-targeted PET reveals peak microglial activation up to two weeks after an epileptogenic brain insult.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.172494.
    PubMed     Text format     Abstract available


  306. HEISS WD
    Hybrid MR/PET Imaging in Neurology: Present Applications and Prospects for the Future.
    J Nucl Med. 2016 Apr 7. pii: jnumed.116.175208.
    PubMed     Text format    


  307. JADVAR H
    SNMMI Leadership Update: Pathways to the Future of Nuclear Medicine.
    J Nucl Med. 2016;57:15N.
    PubMed     Text format    



  308. George E. Thoma, Jr., MD: Launching JNM.
    J Nucl Med. 2016;57:12N-13N.
    PubMed     Text format    


  309. LITTLEFIELD JL, Fletcher JW
    In Memoriam: George E. Thoma, Jr., MD (1922-2016).
    J Nucl Med. 2016;57:11N.
    PubMed     Text format    


  310. PARKER JA
    Value of ABNM Certification and MOC to Diplomates and the Public.
    J Nucl Med. 2016;57:10N.
    PubMed     Text format    


  311. SOLOMON SB, Cornelis F
    Interventional Molecular Imaging.
    J Nucl Med. 2016;57:493-6.
    PubMed     Text format     Abstract available


  312. GRAHAM MM, Weber WA
    Evaluation of the Efficacy of Targeted Imaging Agents.
    J Nucl Med. 2016;57:653-9.
    PubMed     Text format     Abstract available


  313. SOODGUPTA D, Zhou H, Beaino W, Lu L, et al
    Ex Vivo and In Vivo Evaluation of Overexpressed VLA-4 in Multiple Myeloma Using LLP2A Imaging Agents.
    J Nucl Med. 2016;57:640-5.
    PubMed     Text format     Abstract available


  314. BOLKESTEIN M, de Blois E, Koelewijn SJ, Eggermont AM, et al
    Investigation of Factors Determining the Enhanced Permeability and Retention Effect in Subcutaneous Xenografts.
    J Nucl Med. 2016;57:601-7.
    PubMed     Text format     Abstract available


    March 2016
  315. BINSE I, Poeppel TD, Ruhlmann M, Ezziddin S, et al
    68Ga-DOTATOC-PET/CT in patients with iodine- and 18F-FDG-negative differentiated thyroid carcinoma and elevated serum thyroglobulin.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171942.
    PubMed     Text format     Abstract available


  316. LEE HW, Lee HM, Choi SE, Yoo H, et al
    The Prognostic Impact of Early Change in Standardized Uptake Value of 18F-fluorodeoxy-glucose Positron Emission Tomography after Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.166322.
    PubMed     Text format     Abstract available


  317. FAHEY FH, Bom HH, Chiti A, Choi YY, et al
    Standardization of Administered Activities in Pediatric Nuclear Medicine Part 2: A Report of the First Nuclear Medicine Global Initiative.
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.169714.
    PubMed     Text format     Abstract available


  318. UNTERRAINER M, Schweisthal F, Suchorska B, Wenter V, et al
    Serial 18F-FET PET imaging of primarily 18F-FET-negative glioma - does it make sense?
    J Nucl Med. 2016 Mar 31. pii: jnumed.115.171033.
    PubMed     Text format     Abstract available


  319. WAKABAYASHI H, Werner RA, Hayakawa N, Javadi MS, et al
    Initial Preclinical Evaluation of 18F-fluorodeoxysorbitol PET as a Novel Functional Renal Imaging Agent.
    J Nucl Med. 2016 Mar 24. pii: jnumed.116.172718.
    PubMed     Text format     Abstract available


  320. NIELSEN CH, Jeppesen TE, Kristensen LK, Jensen MM, et al
    PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-labeled Active Site Inhibited Factor VII.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.170266.
    PubMed     Text format     Abstract available


  321. JI T, Gao S, Liu Z, Xing H, et al
    99mTc-Glu-c(RGDyK)-bombesin SPECT Can Reduce Unnecessary Biopsy of BI-RADS Category 4 On Ultrasonography.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.168773.
    PubMed     Text format     Abstract available


  322. SEKINE T, Burgos N, Warnock G, Huellner MW, et al
    Multi atlas-based attenuation correction for brain FDG-PET imaging using a TOF-PET/MR scanner- comparison with clinical single atlas- and CT-based attenuation correction.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.169045.
    PubMed     Text format     Abstract available


  323. YANG Y, Bec J, Zhou J, Zhang M, et al
    A high resolution prototype small-animal PET scanner dedicated to mouse brain imaging.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.165886.
    PubMed     Text format     Abstract available


  324. SIBILLE L, Chambert B, Alonso S, Barrau C, et al
    Impact of the Adaptive Statistical iterative Reconstruction (ASiR) technique on radiation dose and image quality in bone SPECT/CT.
    J Nucl Med. 2016 Mar 24. pii: jnumed.115.164772.
    PubMed     Text format     Abstract available


  325. PIERT M, Montgomery J, Kunju LP, Siddiqui J, et al
    18F-choline PET/MRI: the Additional Value of PET for MRI-guided Transrectal Prostate Biopsies.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.170878.
    PubMed     Text format     Abstract available


  326. PINKER K, Riedl C, Ong L, Jochelson M, et al
    Impact of the number of lesions analyzed in metastatic breast cancer on response assessment by 18F-FDG PET/CT using PERCIST.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.166629.
    PubMed     Text format     Abstract available


  327. ZHU Y, Du R, Zhu Y, Shen Y, et al
    PET Mapping of Neurofunctional Changes in a Post-traumatic Stress Disorder Model.
    J Nucl Med. 2016 Mar 16. pii: jnumed.116.173443.
    PubMed     Text format     Abstract available


  328. KIM YI, Paeng JC, Cheon GJ, Suh KS, et al
    Prediction of Post-Transplantation Recurrence of Hepatocellular Carcinoma by Using Metabolic and Volumetric Indices of 18F-FDG PET/CT.
    J Nucl Med. 2016 Mar 16. pii: jnumed.115.170076.
    PubMed     Text format     Abstract available


  329. CHEN R, Zhou X, Liu J, Huang G, et al
    Relationship between 18F-FDG PET-CT scans and HER2 expression in gastric cancer.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171165.
    PubMed     Text format     Abstract available


  330. TIXIER F, Vriens D, Cheze-Le Rest C, Hatt M, et al
    Comparison of tumor uptake heterogeneity characterization between static and parametric 18F-FDG PET images in Non-Small Cell Lung Cancer.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.166918.
    PubMed     Text format     Abstract available


  331. SORENSEN M, Munk OL, Oerntoft N, Frisch K, et al
    Hepatobiliary Secretion Kinetics of Conjugated Bile Acids Measured in Pigs by 11C-Cholylsarcosine PET.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171579.
    PubMed     Text format     Abstract available


  332. HARKNESS BA, Fahey FH
    A Report on the Current State of Nuclear Medicine Physics Training: The Findings of the AAPM/SNMMI Joint Task Force.
    J Nucl Med. 2016 Mar 10. pii: jnumed.115.171355.
    PubMed     Text format    


  333. ULANER GA, Goldman D, Gonen M, Pham H, et al
    Initial results of a prospective clinical trial of 18F-Fluciclovine PET/CT in newly diagnosed invasive ductal and invasive lobular breast cancers.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.170456.
    PubMed     Text format     Abstract available


  334. UEDA S, Yoshizawa N, Shigekawa T, Takeuchi H, et al
    Near-infrared diffuse optical imaging for early prediction of breast cancer response to neoadjuvant chemotherapy: a comparative study using FDG-PET/CT.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.167320.
    PubMed     Text format     Abstract available


  335. VAN WEEHAEGHE D, Ceccarini J, Delva A, Robberecht W, et al
    Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
    J Nucl Med. 2016 Mar 3. pii: jnumed.115.166272.
    PubMed     Text format     Abstract available


  336. O'MALLEY J
    2015 SNMMI Highlights Lecture: General Nuclear Medicine.
    J Nucl Med. 2016;57:13N-8N.
    PubMed     Text format    


  337. METRAN-NASCENTE C, Yeung I, Vines DC, Metser U, et al
    Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on 18F-Fluoroazomyin Arabinoside Uptake.
    J Nucl Med. 2016;57:361-6.
    PubMed     Text format     Abstract available


  338. ALTAI M, Perols A, Tsourma M, Mitran B, et al
    Feasibility of Affibody-Based Bioorthogonal Chemistry-Mediated Radionuclide Pretargeting.
    J Nucl Med. 2016;57:431-6.
    PubMed     Text format     Abstract available


  339. MARQUEZ BV, Lapi SE
    Pretargeted Immuno-PET: Overcoming Limitations of Space and Time.
    J Nucl Med. 2016;57:332-3.
    PubMed     Text format    


  340. TERRY SY, Koenders MI, Franssen GM, Nayak TK, et al
    Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin alphavbeta3.
    J Nucl Med. 2016;57:467-72.
    PubMed     Text format     Abstract available


  341. NABI F, Kassi M, Muhyieddeen K, Chang SM, et al
    Optimizing Evaluation of Patients with Low-to-Intermediate-Risk Acute Chest Pain: A Randomized Study Comparing Stress Myocardial Perfusion Tomography Incorporating Stress-Only Imaging Versus Cardiac CT.
    J Nucl Med. 2016;57:378-84.
    PubMed     Text format     Abstract available


  342. BAHLER L, Verberne HJ, Admiraal WM, Stok WJ, et al
    Differences in Sympathetic Nervous Stimulation of Brown Adipose Tissue Between the Young and Old, and the Lean and Obese.
    J Nucl Med. 2016;57:372-7.
    PubMed     Text format     Abstract available


  343. HOUGHTON JL, Zeglis BM, Abdel-Atti D, Sawada R, et al
    Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
    J Nucl Med. 2016;57:453-9.
    PubMed     Text format     Abstract available


    February 2016
  344. ZHU Y, Xu K, Xu C, Zhang J, et al
    PET Mapping for Brain-Computer-Interface-Based Stimulation in a Rat Model with Intracranial Electrode Implantation in the Ventro-posterior Medial Thalamus.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.171868.
    PubMed     Text format     Abstract available


  345. SONG IH, Lee TS, Park YS, Lee JS, et al
    Immuno-PET Imaging and Radioimmunotherapy of 64Cu-/177Lu-Labeled Anti-EGFR Antibody in Esophageal Squamous Cell Carcinoma Model.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.167155.
    PubMed     Text format     Abstract available


  346. RAUSCH I, Rust P, Difranco MD, Lassen M, et al
    Reproducibility of MRI Dixon-based attenuation correction in combined PET/MR with applications for lean body mass estimation.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168294.
    PubMed     Text format     Abstract available


  347. WIERTS R, Brans B, Havekes B, Kemerink G, et al
    Dose-response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
    J Nucl Med. 2016 Feb 25. pii: jnumed.115.168799.
    PubMed     Text format     Abstract available


  348. YU Y, Chan C, Ma T, Liu Y, et al
    Event-by-Event Continuous Respiratory Motion Correction for Dynamic PET Imaging.
    J Nucl Med. 2016 Feb 23. pii: jnumed.115.167676.
    PubMed     Text format     Abstract available


  349. CORNELIS F, Sotirchos V, Violari E, Sofocleous C, et al
    Fluoro-deoxyglucose PET/CT is an immediate imaging biomarker of treatment success after liver metastasis ablation.
    J Nucl Med. 2016 Feb 23. pii: jnumed.115.171926.
    PubMed     Text format     Abstract available


  350. BRENDEL M, Probst F, Jaworska A, Overhoff F, et al
    Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple Tracer PET Study.
    J Nucl Med. 2016 Feb 18. pii: jnumed.115.167858.
    PubMed     Text format     Abstract available


  351. KRALL N, Pretto F, Mattarella M, Muller C, et al
    A technetium 99m-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo.
    J Nucl Med. 2016 Feb 18. pii: jnumed.115.170514.
    PubMed     Text format     Abstract available


  352. RODRIGUEZ-VIEITEZ E, Carter SF, Chiotis K, Saint-Aubert L, et al
    Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-PiB PET for Assessing Brain Perfusion in Alzheimer's Disease.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.168732.
    PubMed     Text format     Abstract available


  353. ROWE CC, Jones G, Dore V, Pejoska S, et al
    Standardized Expression of 18F-NAV4694 and 11C-PiB beta-Amyloid PET Results with the Centiloid Scale.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.171595.
    PubMed     Text format     Abstract available


  354. LILJA JA, Thurfjell L, Sorensen J
    Visualization and Quantification of Three-Dimensional Stereotactic Surface Projections for 18F-Flutemetamol PET using variable depth.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.169169.
    PubMed     Text format     Abstract available


  355. LEE JH, Sato M, Coel MN, Lee KH, et al
    Prediction of PSA Progression in Castrate-Resistant Prostate Cancer based on Treatment-Associated Change in Tumor Burden Quantified by 18F-fluorocholine PET/CT.
    J Nucl Med. 2016 Feb 16. pii: jnumed.115.169177.
    PubMed     Text format     Abstract available


  356. TSUKADA H, Kanazawa M, Ohba H, Nishiyama S, et al
    PET Imaging of Mitochondrial Complex I with 18F-BCPP-EF in Brain of Parkinson's Disease Model Monkey.
    J Nucl Med. 2016 Feb 11. pii: jnumed.115.169615.
    PubMed     Text format     Abstract available


  357. OHRI N, Duan F, Snyder BS, Wei B, et al
    Pretreatment 18FDG-PET Textural Features in Locally Advanced Non-Small Cell Lung Cancer: Secondary Analysis of ACRIN 6668/RTOG 0235.
    J Nucl Med. 2016 Feb 11. pii: jnumed.115.166934.
    PubMed     Text format     Abstract available


  358. TIAN M
    The Pathophysiologic Basis of Nuclear Medicine.
    J Nucl Med. 2016 Feb 9. pii: jnumed.116.173815.
    PubMed     Text format    


  359. HINDIE E, Zanotti-Fregonara P, Quinto M, Morgat C, et al
    Dose Deposits from 90Y, 177Lu, 111In, and 161Tb in Micrometastases of Various Sizes: Implications for Radiopharmaceutical Therapy.
    J Nucl Med. 2016 Feb 9. pii: jnumed.115.170423.
    PubMed     Text format     Abstract available


  360. NABULSI N, Mercier J, Holden D, Carre S, et al
    Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168179.
    PubMed     Text format     Abstract available


  361. PALYO R, Sinusas A, Liu YH
    High-Sensitivity and High-Resolution SPECT/CT Systems Provide Substantial Dose Reduction without Compromising Quantitative Precision for Assessment of Myocardial Perfusion or Function.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.164632.
    PubMed     Text format     Abstract available


  362. WARNDERS FJ, Waaijer SJ, Pool M, Lub-de Hooge MN, et al
    Biodistribution and PET Imaging of Labeled Bispecific T Cell Engaging Antibody targeting EpCAM.
    J Nucl Med. 2016 Feb 4. pii: jnumed.115.168153.
    PubMed     Text format     Abstract available


  363. KOESTERS T, Friedman KP, Fenchel M, Zhan Y, et al
    Dixon sequence with superimposed model-based bone compartment provides highly accurate PET/MR attenuation correction of the brain.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.166967.
    PubMed     Text format     Abstract available


  364. SHEIKHBAHAEI S, Mena E, Marcus C, Wray R, et al
    18F-Fluorodeoxyglucose PET/CT: Therapy Response Assessment Interpretation (Hopkins Criteria) and Survival Outcomes in Lung Cancer Patients.
    J Nucl Med. 2016 Feb 2. pii: jnumed.115.165480.
    PubMed     Text format     Abstract available


  365. KENNY L
    The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis.
    J Nucl Med. 2016;57 Suppl 1:89S-95S.
    PubMed     Text format     Abstract available


  366. WAHL RL
    Quo Vadis: PET and Single-Photon Molecular Breast Imaging.
    J Nucl Med. 2016;57 Suppl 1:3S-8S.
    PubMed     Text format    


  367. AVRIL S, Muzic RF Jr, Plecha D, Traughber BJ, et al
    18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:34S-9S.
    PubMed     Text format     Abstract available


  368. GROHEUX D, Cochet A, Humbert O, Alberini JL, et al
    18F-FDG PET/CT for Staging and Restaging of Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:17S-26S.
    PubMed     Text format     Abstract available


  369. VAN ES SC, Venema CM, Glaudemans AW, Lub-de Hooge MN, et al
    Translation of New Molecular Imaging Approaches to the Clinical Setting: Bridging the Gap to Implementation.
    J Nucl Med. 2016;57 Suppl 1:96S-104S.
    PubMed     Text format     Abstract available


  370. FOWLER AM, Clark AS, Katzenellenbogen JA, Linden HM, et al
    Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:75S-80S.
    PubMed     Text format     Abstract available


  371. MCDONALD ES, Mankoff DA, Mach RH
    Novel Strategies for Breast Cancer Imaging: New Imaging Agents to Guide Treatment.
    J Nucl Med. 2016;57 Suppl 1:69S-74S.
    PubMed     Text format     Abstract available


  372. ULANER GA, Riedl CC, Dickler MN, Jhaveri K, et al
    Molecular Imaging of Biomarkers in Breast Cancer.
    J Nucl Med. 2016;57 Suppl 1:53S-9S.
    PubMed     Text format     Abstract available


  373. BERG WA
    Nuclear Breast Imaging: Clinical Results and Future Directions.
    J Nucl Med. 2016;57 Suppl 1:46S-52S.
    PubMed     Text format     Abstract available


  374. COOK GJ, Azad GK, Goh V
    Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.
    J Nucl Med. 2016;57 Suppl 1:27S-33S.
    PubMed     Text format     Abstract available


  375. CZERNIN J, Mankoff D
    Introduction and Overview.
    J Nucl Med. 2016;57 Suppl 1:1S-2S.
    PubMed     Text format    


  376. PAPPAS V
    SNMMI Leadership Update: Clinical Trials Network Update.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


  377. SEGALL GM
    Looking to the Future: The ABNM in the Next 10 Years.
    J Nucl Med. 2016;57:12N.
    PubMed     Text format    


  378. KRONAUGE J, Packard AB
    In Memoriam: Alan Davison, PhD, 1936-2015.
    J Nucl Med. 2016;57:11N-5N.
    PubMed     Text format    


  379. KOO P
    2015 Kocemba-Slosky Fellowship.
    J Nucl Med. 2016;57:10N.
    PubMed     Text format    


  380. GRADY E
    Gastrointestinal Bleeding Scintigraphy in the Early 21st Century.
    J Nucl Med. 2016;57:252-9.
    PubMed     Text format     Abstract available


  381. TAKAGI G, Miyamoto M, Fukushima Y, Yasutake M, et al
    Imaging Angiogenesis Using 99mTc-Macroaggregated Albumin Scintigraphy in Patients with Peripheral Artery Disease.
    J Nucl Med. 2016;57:192-7.
    PubMed     Text format     Abstract available


  382. GAO L, Liu H, Sun X, Gao D, et al
    Molecular Imaging of Post-Src Inhibition Tumor Signatures for Guiding Dasatinib Combination Therapy.
    J Nucl Med. 2016;57:321-6.
    PubMed     Text format     Abstract available


    January 2016
  383. LIU D DR, Khong PL, Gao Y, Mahmood U, et al
    Radiation Dosimetry of Whole-Body Dual Tracer 18F-FDG and 11C-Acetate PET/CT for Hepatocellular Carcinoma.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.165944.
    PubMed     Text format     Abstract available


  384. BURGER IA, Casanova R, Steiger S, Husmann L, et al
    FDG-PET/CT of non-small cell lung carcinoma under neo-adjuvant chemotherapy: background based adaptive volume metrics outperform TLG and MTV in predicting histopathological response.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.167684.
    PubMed     Text format     Abstract available


  385. TEUHO J, Johansson J, Liden J, Hansen AE, et al
    Effect of attenuation correction to regional quantification between PET/MR and PET/CT: a multi-centre study using a three-dimensional brain phantom.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.166165.
    PubMed     Text format     Abstract available


  386. BOLLINENI VR, Ytre-Hauge S, Bollineni-Balabay O, Salvesen H, et al
    High diagnostic value of FDG-PET/CT in endometrial cancer: Systematic review and meta-analysis of the literature.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.170597.
    PubMed     Text format     Abstract available


  387. SU Y, Rubin B, McConathy J, Laforest R, et al
    Impact of MR based attenuation correction on neurological PET studies.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.164822.
    PubMed     Text format     Abstract available


  388. SEIBYL J, Catafau AM, Barthel H, Ishii K, et al
    Impact of training method on the robustness of the visual assessment of 18F-florbetaben PET scans: results from a Phase 3 trial.
    J Nucl Med. 2016 Jan 28. pii: jnumed.115.161927.
    PubMed     Text format     Abstract available


  389. APOLO AB, Lindenberg L, Shih JH, Mena E, et al
    Prospective Study Evaluating Na18F-Positron Emission Tomography/Computed Tomography (NaF-PET/CT) in Predicting Clinical Outcomes and Survival in Advanced Prostate Cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166512.
    PubMed     Text format     Abstract available


  390. LUO Y, Pan Q, Shao Y, Yu M, et al
    Glucagon-like Peptide-1 Receptor PET/CT with 68Ga-NOTA-exendin-4 for Detecting Localized Insulinoma: a Prospective Cohort Study.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.167445.
    PubMed     Text format     Abstract available


  391. JONASSON M, Wall A, Chiotis K, Saint-Aubert L, et al
    Tracer kinetic analysis of (S)-18F-THK5117 as a PET tracer for assessing tau pathology.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.158519.
    PubMed     Text format     Abstract available


  392. O JH, Luber BS, Leal JP, Wang H, et al
    Response to early treatment evaluated with 18F-FDG PET and PERCIST 1.0 predicts survival in patients with Ewing sarcoma family of tumors treated with a monoclonal antibody to the insulin-like growth factor 1 receptor.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.162412.
    PubMed     Text format     Abstract available


  393. VAN ROSSUM PS, Fried DV, Zhang L, Hofstetter WL, et al
    The incremental value of subjective and quantitative assessment of 18F-FDG PET for the prediction of pathologic complete response to preoperative chemoradiotherapy in esophageal cancer.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.163766.
    PubMed     Text format     Abstract available


  394. LUEHMANN HP, Detering L, Fors BP, Pressly ED, et al
    PET/CT Imaging of Chemokine Receptors in Inflammatory Atherosclerosis Using Targeted Nanoparticles.
    J Nucl Med. 2016 Jan 21. pii: jnumed.115.166751.
    PubMed     Text format     Abstract available


  395. VAG T, Gerngross C, Herhaus P, Eiber M, et al
    First Experience on Chemokine Receptor CXCR4 Targeted Positron Emission Tomography (PET) Imaging in Patients with Solid Cancers.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161034.
    PubMed     Text format     Abstract available


  396. DEPPEN SA, Liu E, Blume JD, Clanton J, et al
    Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging and Treatment Management of Neuroendocrine Tumors.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.163865.
    PubMed     Text format     Abstract available


  397. VILCHE MB, Reyes AL, Vasilskis E, Oliver P, et al
    68Ga-NOTA-UBI 29-41 as a PET tracer for detection of bacterial infection.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.161265.
    PubMed     Text format     Abstract available


  398. JAKOBSEN S, Busk M, Jensen JB, Munk OL, et al
    A PET Tracer For Renal Organic Cation Transporters, 11C-metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
    J Nucl Med. 2016 Jan 14. pii: jnumed.115.169292.
    PubMed     Text format     Abstract available


  399. SAWICKI LM, Grueneisen J, Buchbender C, Schaarschmidt BM, et al
    Comparative performance of 18F-FDG PET/MRI and 18F-FDG PET/CT regarding detection and characterization of pulmonary lesions in 121 oncologic patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.167486.
    PubMed     Text format     Abstract available


  400. KIM EE
    Nuclear Medicine and PET/CT Cases.
    J Nucl Med. 2016 Jan 7. pii: jnumed.116.172114.
    PubMed     Text format    


  401. SPICK C, Herrmann K, Czernin J
    18F-FDG PET/CT and PET/MRI perform equally well in cancer patients: Evidence from studies in more than 2300 patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.158808.
    PubMed     Text format     Abstract available


  402. FENDLER WP, Lechner H, Todica A, Paprottka KJ, et al
    Safety, efficacy and prognostic factors after radioembolization of hepatic metastases from breast cancer: A large single center experience in 81 patients.
    J Nucl Med. 2016 Jan 7. pii: jnumed.115.165050.
    PubMed     Text format     Abstract available


  403. JADVAR H
    SNMMI Leadership Update: The Future of Nuclear Medicine.
    J Nucl Med. 2016;57:13N.
    PubMed     Text format    


  404. WALKER M, Ehrlichmann W, Stahlschmidt A, Pichler BJ, et al
    In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
    J Nucl Med. 2016;57:115-21.
    PubMed     Text format     Abstract available


  405. TRIPATHI M, Tang CC, Feigin A, De Lucia I, et al
    Automated Differential Diagnosis of Early Parkinsonism Using Metabolic Brain Networks: A Validation Study.
    J Nucl Med. 2016;57:60-6.
    PubMed     Text format     Abstract available


  406. LARSON SM
    EXINI Quantitative Bone Scan Index: Expanded Utility for the Planar Radionuclide Bone Scan.
    J Nucl Med. 2016;57:5-6.
    PubMed     Text format    


  407. URBAIN JL
    Coagulation Factor and Theranostics: A New Paradigm in Molecular Imaging.
    J Nucl Med. 2016;57:7-8.
    PubMed     Text format    


    December 2015
  408. DECAZES P, Metivier D, Rouquette A, Talbot JN, et al
    A method to improve the semi-quantification of 18F-fluorodeoxyglucose uptake : reliability of the estimated lean body mass using a limited field of acquisition, low dose CT from PET/CT.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.164913.
    PubMed     Text format     Abstract available


  409. SCHODER H, Zelenetz A, Hamlin P, Gavane S, et al
    Prospective Study of FLT PET for Early Interim Response Assessment in Advanced Stage B-cell Lymphoma.
    J Nucl Med. 2015 Dec 30. pii: jnumed.115.166769.
    PubMed     Text format     Abstract available


  410. GROHEUX D, Biard L, Giacchetti S, Teixeira L, et al
    18FDG-PET/CT for the early evaluation of response to neoadjuvant treatment in triple negative breast cancer: influence of the chemotherapy regimen.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163907.
    PubMed     Text format     Abstract available


  411. TAGO T, Furumoto S, Okamura N, Harada R, et al
    Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer's Disease.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.166652.
    PubMed     Text format     Abstract available


  412. SCHACHT AC, Sorensen M, Munk OL, Frisch K, et al
    Radiosynthesis of novel N-11C-methyl-taurine conjugated bile acids and biodistribution studies in pigs by PET/CT.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.161711.
    PubMed     Text format     Abstract available


  413. OPREA-LAGER DE, Kramer G, van de Ven P, van den Eertwegh A, et al
    Repeatability of quantitative 18F-fluoromethylcholine PET/CT studies in prostate cancer.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.167692.
    PubMed     Text format     Abstract available


  414. VIVASH LE, O'Brien TJ
    Imaging microglial activation with TSPO PET: Lighting up neurological diseases?
    J Nucl Med. 2015 Dec 23. pii: jnumed.114.141713.
    PubMed     Text format     Abstract available


  415. AN HJ, Seo S, Kang H, Choi H, et al
    MRI-Based Attenuation Correction for PET/MRI Using Multiphase Level-Set Method.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.163550.
    PubMed     Text format     Abstract available


  416. GROGG K, Toole T, Ouyang J, Zhu X, et al
    NEMA and clinical evaluation of a novel brain PET-CT scanner.
    J Nucl Med. 2015 Dec 23. pii: jnumed.115.159723.
    PubMed     Text format     Abstract available


  417. KIM SJ, Cho YS, Moon SH, Bae JM, et al
    Primary Tumor FDG Avidity Affects the Performance of FDG PET/CT for Detecting Gastric Cancer Recurrence.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.163295.
    PubMed     Text format     Abstract available


  418. HOOGENDAM JP, Zweemer RP, Hobbelink MG, van den Bosch MA, et al
    99mTc-nanocolloid SPECT-MRI fusion for the selective assessment of non-enlarged sentinel lymph nodes in patients with early stage cervical cancer.
    J Nucl Med. 2015 Dec 17. pii: jnumed.115.164780.
    PubMed     Text format     Abstract available


  419. DIVINE MR, Katiyar P, Kohlhofer U, Quintanilla-Martinez L, et al
    A Population Based Gaussian Mixture Model Incorporating 18F-FDG-PET and DW-MRI Quantifies Tumor Tissue Classes.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.163972.
    PubMed     Text format     Abstract available


  420. IQBAL R, Kramer GM, Verwer EE, Huisman MC, et al
    Multiparametric analysis of the relationship between tumor hypoxia and perfusion using 18F-FAZA and 15O-H2O PET.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166579.
    PubMed     Text format     Abstract available


  421. SCHOLTENS AM, Verberne HJ, Budde RP, Lam M, et al
    Additional heparin pre-administration improves cardiac glucose metabolism suppression over low carbohydrate diet alone in 18F-FDG-PET imaging.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.166884.
    PubMed     Text format     Abstract available


  422. MINAMIMOTO R, Hancock S, Schneider B, Chin F, et al
    Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer.
    J Nucl Med. 2015 Dec 10. pii: jnumed.115.168393.
    PubMed     Text format     Abstract available


  423. FUKUSHIMA Y, Kumita SI, Tokita Y, Sato N, et al
    Prognostic value of myocardial perfusion SPECT following intravenous bolus administration of nicorandil in patients with acute ischemic heart failure.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.162420.
    PubMed     Text format     Abstract available


  424. DE SWART J, Chan HS, Goorden MC, Morgenstern A, et al
    Utilizing high-energy gamma photons for high-resolution 213Bi SPECT in mice.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.157685.
    PubMed     Text format     Abstract available


  425. ARULAPPU A, Battle M, Eisenblaetter M, McRobbie G, et al
    c-Met PET Imaging Detects Early Stage Loco-Regional Recurrence of Basal-Like Breast Cancer.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.164384.
    PubMed     Text format     Abstract available


  426. PRIOR JO, Peguret N, Pomoni A, Pappon M, et al
    Reduction of Respiratory Motion during PET/CT by Pulsatile-Flow Ventilation (PFV-PET/CT): A First Clinical Evaluation.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.163386.
    PubMed     Text format     Abstract available


  427. NOTNI J, Steiger K, Hoffmann F, Reich D, et al
    Complementary, Selective PET-Imaging of Integrin Subtypes alpha5beta1 and alphavbeta3 Using Ga-68-Aquibeprin and Ga-68-Avebetrin.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165720.
    PubMed     Text format     Abstract available


  428. MACDONALD L, Hippe D, Bender L, Cotter E, et al
    Positron emission mammography image interpretation for reduced image count levels.
    J Nucl Med. 2015 Dec 3. pii: jnumed.115.165787.
    PubMed     Text format     Abstract available


    November 2015
  429. AARNTZEN E, Hermsen R, Drenth J, Boerman O, et al
    Tc-99m-CXCL8 SPECT to monitor disease activity in inflammatory bowel disease.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165795.
    PubMed     Text format     Abstract available


  430. NIU G, Chen X
    RGD PET: From Lesion Detection to Therapy Response Monitoring.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168278.
    PubMed     Text format    


  431. KIST JW, de Keizer B, van der Vlies M, Brouwers AH, et al
    124I PET/CT to predict the outcome of blind 131I treatment in patients with biochemical recurrence of differentiated thyroid cancer; results of a multicenter diagnostic cohort study (THYROPET).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.168138.
    PubMed     Text format     Abstract available


  432. RUF J, von Wedel F, Furth C, Denecke T, et al
    Significance of a single time point hybrid-protocol for somatostatin receptor SPECT including multiphase CT in the diagnostic work-up of gastroenteoropancreatic neuroendocrine Neoplasms (GEP-NEN).
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.161117.
    PubMed     Text format     Abstract available


  433. MICHL M, Lehner S, Paprottka PM, Ilhan H, et al
    PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer.
    J Nucl Med. 2015 Nov 25. pii: jnumed.115.165613.
    PubMed     Text format     Abstract available


  434. LOPEZ-RODRIGUEZ V, Galindo-Sarco C, Garcia-Perez FO, Ferro-Flores G, et al
    PET-Based Human Dosimetry of the Dimeric alphavbeta3 Integrin Ligand 68Ga-DOTA-E-[c(RGDfK)]2, a Potential Tracer for Imaging Tumor Angiogenesis.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.161653.
    PubMed     Text format     Abstract available


  435. PYKA T, Weirich G, Einspieler I, Maurer T, et al
    [68Ga]PSMA-HBED PET for differential diagnosis of suspicious lung lesions in patients with prostate cancer.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164442.
    PubMed     Text format     Abstract available


  436. WATANABE S, Kato H, Shimosegawa E, Hatazawa J, et al
    Genetic and Environmental Influences on Regional Brain Uptake of 2-deoxy-2-[18F]fluoro-D-glucose: a PET Study in Monozygotic and Dizygotic Twins.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.164004.
    PubMed     Text format     Abstract available


  437. TAHMASIAN M, Shao J, Meng C, Grimmer T, et al
    Based on the network degeneration hypothesis: separating individual patients with different neurodegenerative syndromes in a preliminary hybrid PET/MR study.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.165464.
    PubMed     Text format     Abstract available


  438. GRIMMER T, Wutz C, Alexopoulos P, Drzezga A, et al
    Visual versus fully-automated analyses of FDG- and Amyloid-PET for prediction of dementia due to Alzheimer's disease in mild cognitive impairment.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.163717.
    PubMed     Text format     Abstract available


  439. SHUKURI M, Mawatari A, Ohno M, Suzuki M, et al
    Detection of cyclooxygenase-1 in activated microglia during amyloid plaque progression: PET studies in Alzheimer's disease model mice.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.166116.
    PubMed     Text format     Abstract available


  440. LI F, Jorgensen JT, Forman J, Hansen AE, et al
    64Cu-ATSM reflects pO2 levels in human head and neck cancer xenografts but not in colorectal cancer xenografts.
    J Nucl Med. 2015 Nov 19. pii: jnumed.115.155663.
    PubMed     Text format     Abstract available


  441. JALLOW N, Christian PE, Sunderland J, Graham MM, et al
    Diagnostic Reference Levels of CT Radiation Dose in Oncology Whole-Body PET/CT.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160465.
    PubMed     Text format     Abstract available


  442. KIM EE
    Therapeutic Nuclear Medicine.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.169300.
    PubMed     Text format    


  443. JANSSEN I, Chen CC, Taieb D, Patronas NJ, et al
    68Ga-DOTATATE PET/CT in the localization of head and neck paragangliomas compared to other functional imaging modalities and CT/MRI.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161018.
    PubMed     Text format     Abstract available


  444. SPIELMANN V, Li WB, Zankl M, Oeh U, et al
    Uncertainty Quantification in Internal Dose Calculations for Seven Selected Radiopharmaceuticals.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.160713.
    PubMed     Text format     Abstract available


  445. KANAZAWA M, Ohba H, Harada N, Kakiuchi T, et al
    Evaluation of 6-11C-Methyl-m-tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with beta-11-L-DOPA and 18F-FDOPA in Parkinson's Disease Monkeys.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161802.
    PubMed     Text format     Abstract available


  446. CHENG SH, Yu D, Tsai HM, Morshed RA, et al
    Dynamic In Vivo SPECT Imaging of Neural Stem Cells Functionalized with Radiolabeled Nanoparticles for Tracking of Glioblastoma.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.163006.
    PubMed     Text format     Abstract available


  447. LAFFON E, Burger IA, Lamare F, de Clermont-Gallerande H, et al
    SUVpeak performance in Lung Cancer: Comparison to Average SUV from 40 Hottest Voxels.
    J Nucl Med. 2015 Nov 12. pii: jnumed.115.161968.
    PubMed     Text format     Abstract available


  448. MAHMOOD U
    2015 SNMMI Highlights Lecture: Oncology, Part I.
    J Nucl Med. 2015;56:9N-16N.
    PubMed     Text format    


  449. JADVAR H
    SNMMI Leadership Update: Developing Evidence-Based Appropriate Use Criteria under the Protecting Access to Medicare Act of 2014.
    J Nucl Med. 2015;56:20N.
    PubMed     Text format    


  450. JERAJ R, Bradshaw T, Simoncic U
    Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy.
    J Nucl Med. 2015;56:1752-65.
    PubMed     Text format     Abstract available


  451. WAHL RL, Horner TJ, Lin TS, Kaminski MS, et al
    Observational Retrospective Study of Altered Biodistribution of Tositumomab and 131I-Tositumomab.
    J Nucl Med. 2015;56:1800-3.
    PubMed     Text format     Abstract available


  452. ILHAN H, Goritschan A, Paprottka P, Jakobs TF, et al
    Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    J Nucl Med. 2015;56:1654-60.
    PubMed     Text format     Abstract available


  453. FROKLAGE FE, Boellaard R, Bakker E, Hendrikse NH, et al
    Quantification of 11C-Laniquidar Kinetics in the Brain.
    J Nucl Med. 2015;56:1730-5.
    PubMed     Text format     Abstract available


  454. DUBROFF JG, Doot RK, Falcone M, Schnoll RA, et al
    Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism.
    J Nucl Med. 2015;56:1724-9.
    PubMed     Text format     Abstract available


    October 2015
  455. WEBER WA, Gatsonis C, Siegel B
    Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1636.
    PubMed     Text format    


  456. VAN DEN HOFF J, Hofheinz F
    Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
    J Nucl Med. 2015;56:1635-6.
    PubMed     Text format    


  457. BOHNEN NI
    2015 SNMMI Highlights Lecture: Neurosciences.
    J Nucl Med. 2015;56:13N-20N.
    PubMed     Text format    


  458. COLLAMATI F, Bellini F, Bocci V, De Lucia E, et al
    Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with beta- Decay.
    J Nucl Med. 2015;56:1501-6.
    PubMed     Text format     Abstract available


  459. OLIVEIRA BL, Blasi F, Rietz TA, Rotile NJ, et al
    Multimodal Molecular Imaging Reveals High Target Uptake and Specificity of 111In- and 68Ga-Labeled Fibrin-Binding Probes for Thrombus Detection in Rats.
    J Nucl Med. 2015;56:1587-92.
    PubMed     Text format     Abstract available


  460. SELIVANOVA SV, Lavallee E, Senta H, Caouette L, et al
    Radioisotopic Purity of Sodium Pertechnetate 99mTc Produced with a Medium-Energy Cyclotron: Implications for Internal Radiation Dose, Image Quality, and Release Specifications.
    J Nucl Med. 2015;56:1600-8.
    PubMed     Text format     Abstract available


  461. PERSSON M, Nedergaard M, Brandt-Larsen M, Skovgaard D, et al
    uPAR is a Promising New Imaging Biomarker in Glioblastoma.
    J Nucl Med. 2015 Oct 1. pii: jnumed.115.161703.
    PubMed     Text format     Abstract available


    September 2015
  462. TRAXL A, Wanek T, Mairinger S, Stanek J, et al
    Breast Cancer Resistance Protein and P-glycoprotein Influence In Vivo Disposition of 11C-Erlotinib.
    J Nucl Med. 2015 Sep 10. pii: jnumed.115.161273.
    PubMed     Text format     Abstract available


  463. DILSIZIAN V
    2015 SNMMI Highlights Lecture: Cardiovascular Nuclear and Molecular Imaging.
    J Nucl Med. 2015;56:13N-9N.
    PubMed     Text format    


  464. KING MT, Carpenter CM, Sun C, Ma X, et al
    beta-Radioluminescence Imaging: A Comparative Evaluation with Cerenkov Luminescence Imaging.
    J Nucl Med. 2015;56:1458-64.
    PubMed     Text format     Abstract available


  465. ZIMMERMAN BE, Bergeron DE, Cessna JT
    Impact of Recent Change in the National Institute of Standards and Technology Standard for 18F on the Relative Response of 68Ge-Based Mock Syringe Dose Calibrator Standards.
    J Nucl Med. 2015;56:1453-7.
    PubMed     Text format     Abstract available


  466. VAN DUIJNHOVEN SM, Rossin R, van den Bosch SM, Wheatcroft MP, et al
    Diabody Pretargeting with Click Chemistry In Vivo.
    J Nucl Med. 2015;56:1422-8.
    PubMed     Text format     Abstract available


  467. MAURER AH
    Gastrointestinal Motility, Part 2: Small-Bowel and Colon Transit.
    J Nucl Med. 2015;56:1395-400.
    PubMed     Text format     Abstract available


  468. KEIDING S
    How Should Lumped Constant Be Estimated for Hepatic 18F-FDG Glucose in Humans?
    J Nucl Med. 2015;56:1302-3.
    PubMed     Text format    


  469. MACHULLA HJ
    Imaging of Apoptosis: The Need to Distinguish Tracer Uptake Rate from Regional Contribution of Blood Flow.
    J Nucl Med. 2015;56:1300-1.
    PubMed     Text format    


    August 2015
  470. ANAND A, Morris MJ, Kaboteh R, Bath L, et al
    Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
    J Nucl Med. 2015 Aug 27. pii: jnumed.115.160085.
    PubMed     Text format     Abstract available


  471. STENDAHL J, Sinusas AJ
    Nanoparticles for cardiovascular imaging and therapeutic delivery, Part 2: Radiolabeled probes.
    J Nucl Med. 2015 Aug 20. pii: jnumed.115.164145.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: